id	sid	tid	token	lemma	pos
ajbspi-70150	1	1	american	american	PROPN
ajbspi-70150	1	2	journal	journal	PROPN
ajbspi-70150	1	3	of	of	ADP
ajbspi-70150	1	4	biomedical	biomedical	PROPN
ajbspi-70150	1	5	science	science	PROPN
ajbspi-70150	1	6	&	&	CCONJ
ajbspi-70150	1	7	pharmaceutical	pharmaceutical	PROPN
ajbspi-70150	1	8	innovation	innovation	NOUN
ajbspi-70150	1	9	17	17	NUM
ajbspi-70150	1	10	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-70150	1	11	volume	volume	NOUN
ajbspi-70150	1	12	vol.05	vol.05	NOUN
ajbspi-70150	1	13	issue02	issue02	ADJ
ajbspi-70150	1	14	2025	2025	NUM
ajbspi-70150	1	15	page	page	NOUN
ajbspi-70150	1	16	no	no	INTJ
ajbspi-70150	1	17	.	.	NOUN
ajbspi-70150	2	1	17	17	NUM
ajbspi-70150	2	2	-	-	SYM
ajbspi-70150	2	3	19	19	NUM
ajbspi-70150	2	4	doi	doi	NOUN
ajbspi-70150	2	5	10.37547	10.37547	NUM
ajbspi-70150	2	6	/	/	SYM
ajbspi-70150	2	7	ajbspi	ajbspi	NOUN
ajbspi-70150	2	8	/	/	SYM
ajbspi-70150	2	9	volume05issue02	volume05issue02	NOUN
ajbspi-70150	2	10	-	-	PUNCT
ajbspi-70150	2	11	05	05	NUM
ajbspi-70150	2	12	risk	risk	NOUN
ajbspi-70150	2	13	factors	factor	NOUN
ajbspi-70150	2	14	for	for	ADP
ajbspi-70150	2	15	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	2	16	development	development	NOUN
ajbspi-70150	2	17	in	in	ADP
ajbspi-70150	2	18	patients	patient	NOUN
ajbspi-70150	2	19	with	with	ADP
ajbspi-70150	2	20	systemic	systemic	ADJ
ajbspi-70150	2	21	scleroderma	scleroderma	NOUN
ajbspi-70150	2	22	ganieva	ganieva	PROPN
ajbspi-70150	2	23	n.a	n.a	PROPN
ajbspi-70150	2	24	.	.	PROPN
ajbspi-70150	2	25	tashkent	tashkent	PROPN
ajbspi-70150	2	26	medical	medical	PROPN
ajbspi-70150	2	27	academy	academy	PROPN
ajbspi-70150	2	28	,	,	PUNCT
ajbspi-70150	2	29	tashkent	tashkent	PROPN
ajbspi-70150	2	30	,	,	PUNCT
ajbspi-70150	2	31	uzbekistan	uzbekistan	PROPN
ajbspi-70150	2	32	ziyaeva	ziyaeva	PROPN
ajbspi-70150	2	33	f.k	f.k	PROPN
ajbspi-70150	2	34	.	.	PROPN
ajbspi-70150	2	35	tashkent	tashkent	PROPN
ajbspi-70150	2	36	medical	medical	PROPN
ajbspi-70150	2	37	academy	academy	PROPN
ajbspi-70150	2	38	,	,	PUNCT
ajbspi-70150	2	39	tashkent	tashkent	PROPN
ajbspi-70150	2	40	,	,	PUNCT
ajbspi-70150	2	41	uzbekistan	uzbekistan	PROPN
ajbspi-70150	2	42	dwivedi	dwivedi	PROPN
ajbspi-70150	2	43	k.	k.	PROPN
ajbspi-70150	2	44	tashkent	tashkent	PROPN
ajbspi-70150	2	45	medical	medical	PROPN
ajbspi-70150	2	46	academy	academy	PROPN
ajbspi-70150	2	47	,	,	PUNCT
ajbspi-70150	2	48	tashkent	tashkent	PROPN
ajbspi-70150	2	49	,	,	PUNCT
ajbspi-70150	2	50	uzbekistan	uzbekistan	PROPN
ajbspi-70150	2	51	koli	koli	PROPN
ajbspi-70150	2	52	v.	v.	PROPN
ajbspi-70150	2	53	tashkent	tashkent	PROPN
ajbspi-70150	2	54	medical	medical	PROPN
ajbspi-70150	2	55	academy	academy	PROPN
ajbspi-70150	2	56	,	,	PUNCT
ajbspi-70150	2	57	tashkent	tashkent	PROPN
ajbspi-70150	2	58	,	,	PUNCT
ajbspi-70150	2	59	uzbekistan	uzbekistan	PROPN
ajbspi-70150	2	60	received	receive	VERB
ajbspi-70150	2	61	:	:	PUNCT
ajbspi-70150	2	62	17	17	NUM
ajbspi-70150	2	63	december	december	PROPN
ajbspi-70150	2	64	2024	2024	NUM
ajbspi-70150	2	65	;	;	PUNCT
ajbspi-70150	2	66	accepted	accept	VERB
ajbspi-70150	2	67	:	:	PUNCT
ajbspi-70150	2	68	19	19	NUM
ajbspi-70150	2	69	january	january	NOUN
ajbspi-70150	2	70	2025	2025	NUM
ajbspi-70150	2	71	;	;	PUNCT
ajbspi-70150	2	72	published	publish	VERB
ajbspi-70150	2	73	:	:	PUNCT
ajbspi-70150	2	74	21	21	NUM
ajbspi-70150	2	75	february	february	NOUN
ajbspi-70150	2	76	2025	2025	NUM
ajbspi-70150	2	77	abstract	abstract	NOUN
ajbspi-70150	2	78	:	:	PUNCT
ajbspi-70150	2	79	systemic	systemic	ADJ
ajbspi-70150	2	80	scleroderma	scleroderma	NOUN
ajbspi-70150	2	81	(	(	PUNCT
ajbspi-70150	2	82	ssc	ssc	NOUN
ajbspi-70150	2	83	)	)	PUNCT
ajbspi-70150	2	84	,	,	PUNCT
ajbspi-70150	2	85	also	also	ADV
ajbspi-70150	2	86	known	know	VERB
ajbspi-70150	2	87	as	as	ADP
ajbspi-70150	2	88	systemic	systemic	ADJ
ajbspi-70150	2	89	sclerosis	sclerosis	NOUN
ajbspi-70150	2	90	,	,	PUNCT
ajbspi-70150	2	91	is	be	AUX
ajbspi-70150	2	92	a	a	DET
ajbspi-70150	2	93	rare	rare	ADJ
ajbspi-70150	2	94	autoimmune	autoimmune	ADJ
ajbspi-70150	2	95	disorder	disorder	NOUN
ajbspi-70150	2	96	characterized	characterize	VERB
ajbspi-70150	2	97	by	by	ADP
ajbspi-70150	2	98	fibrosis	fibrosis	NOUN
ajbspi-70150	2	99	of	of	ADP
ajbspi-70150	2	100	the	the	DET
ajbspi-70150	2	101	skin	skin	NOUN
ajbspi-70150	2	102	and	and	CCONJ
ajbspi-70150	2	103	internal	internal	ADJ
ajbspi-70150	2	104	organs	organ	NOUN
ajbspi-70150	2	105	,	,	PUNCT
ajbspi-70150	2	106	as	as	ADV
ajbspi-70150	2	107	well	well	ADV
ajbspi-70150	2	108	as	as	ADP
ajbspi-70150	2	109	vascular	vascular	ADJ
ajbspi-70150	2	110	abnormalities	abnormality	NOUN
ajbspi-70150	2	111	.	.	PUNCT
ajbspi-70150	3	1	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	3	2	,	,	PUNCT
ajbspi-70150	3	3	the	the	DET
ajbspi-70150	3	4	accumulation	accumulation	NOUN
ajbspi-70150	3	5	of	of	ADP
ajbspi-70150	3	6	lipids	lipid	NOUN
ajbspi-70150	3	7	and	and	CCONJ
ajbspi-70150	3	8	fibrous	fibrous	ADJ
ajbspi-70150	3	9	tissue	tissue	NOUN
ajbspi-70150	3	10	in	in	ADP
ajbspi-70150	3	11	arterial	arterial	ADJ
ajbspi-70150	3	12	walls	wall	NOUN
ajbspi-70150	3	13	,	,	PUNCT
ajbspi-70150	3	14	is	be	AUX
ajbspi-70150	3	15	a	a	DET
ajbspi-70150	3	16	significant	significant	ADJ
ajbspi-70150	3	17	cause	cause	NOUN
ajbspi-70150	3	18	of	of	ADP
ajbspi-70150	3	19	cardiovascular	cardiovascular	ADJ
ajbspi-70150	3	20	morbidity	morbidity	NOUN
ajbspi-70150	3	21	and	and	CCONJ
ajbspi-70150	3	22	mortality	mortality	NOUN
ajbspi-70150	3	23	.	.	PUNCT
ajbspi-70150	4	1	patients	patient	NOUN
ajbspi-70150	4	2	with	with	ADP
ajbspi-70150	4	3	systemic	systemic	ADJ
ajbspi-70150	4	4	scleroderma	scleroderma	NOUN
ajbspi-70150	4	5	are	be	AUX
ajbspi-70150	4	6	at	at	ADP
ajbspi-70150	4	7	an	an	DET
ajbspi-70150	4	8	elevated	elevated	ADJ
ajbspi-70150	4	9	risk	risk	NOUN
ajbspi-70150	4	10	for	for	ADP
ajbspi-70150	4	11	developing	develop	VERB
ajbspi-70150	4	12	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	4	13	,	,	PUNCT
ajbspi-70150	4	14	with	with	ADP
ajbspi-70150	4	15	vascular	vascular	ADJ
ajbspi-70150	4	16	damage	damage	NOUN
ajbspi-70150	4	17	playing	play	VERB
ajbspi-70150	4	18	a	a	DET
ajbspi-70150	4	19	central	central	ADJ
ajbspi-70150	4	20	role	role	NOUN
ajbspi-70150	4	21	in	in	ADP
ajbspi-70150	4	22	its	its	PRON
ajbspi-70150	4	23	pathogenesis	pathogenesis	NOUN
ajbspi-70150	4	24	.	.	PUNCT
ajbspi-70150	5	1	this	this	DET
ajbspi-70150	5	2	article	article	NOUN
ajbspi-70150	5	3	reviews	review	VERB
ajbspi-70150	5	4	the	the	DET
ajbspi-70150	5	5	multifactorial	multifactorial	ADJ
ajbspi-70150	5	6	risk	risk	NOUN
ajbspi-70150	5	7	factors	factor	NOUN
ajbspi-70150	5	8	contributing	contribute	VERB
ajbspi-70150	5	9	to	to	ADP
ajbspi-70150	5	10	the	the	DET
ajbspi-70150	5	11	development	development	NOUN
ajbspi-70150	5	12	of	of	ADP
ajbspi-70150	5	13	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	5	14	in	in	ADP
ajbspi-70150	5	15	patients	patient	NOUN
ajbspi-70150	5	16	with	with	ADP
ajbspi-70150	5	17	systemic	systemic	ADJ
ajbspi-70150	5	18	scleroderma	scleroderma	NOUN
ajbspi-70150	5	19	,	,	PUNCT
ajbspi-70150	5	20	focusing	focus	VERB
ajbspi-70150	5	21	on	on	ADP
ajbspi-70150	5	22	endothelial	endothelial	ADJ
ajbspi-70150	5	23	dysfunction	dysfunction	NOUN
ajbspi-70150	5	24	,	,	PUNCT
ajbspi-70150	5	25	chronic	chronic	ADJ
ajbspi-70150	5	26	inflammation	inflammation	NOUN
ajbspi-70150	5	27	,	,	PUNCT
ajbspi-70150	5	28	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	5	29	,	,	PUNCT
ajbspi-70150	5	30	and	and	CCONJ
ajbspi-70150	5	31	other	other	ADJ
ajbspi-70150	5	32	clinical	clinical	ADJ
ajbspi-70150	5	33	factors	factor	NOUN
ajbspi-70150	5	34	.	.	PUNCT
ajbspi-70150	6	1	the	the	DET
ajbspi-70150	6	2	goal	goal	NOUN
ajbspi-70150	6	3	of	of	ADP
ajbspi-70150	6	4	this	this	DET
ajbspi-70150	6	5	article	article	NOUN
ajbspi-70150	6	6	is	be	AUX
ajbspi-70150	6	7	to	to	PART
ajbspi-70150	6	8	enhance	enhance	VERB
ajbspi-70150	6	9	the	the	DET
ajbspi-70150	6	10	understanding	understanding	NOUN
ajbspi-70150	6	11	of	of	ADP
ajbspi-70150	6	12	cardiovascular	cardiovascular	ADJ
ajbspi-70150	6	13	risk	risk	NOUN
ajbspi-70150	6	14	in	in	ADP
ajbspi-70150	6	15	this	this	DET
ajbspi-70150	6	16	population	population	NOUN
ajbspi-70150	6	17	and	and	CCONJ
ajbspi-70150	6	18	emphasize	emphasize	VERB
ajbspi-70150	6	19	the	the	DET
ajbspi-70150	6	20	importance	importance	NOUN
ajbspi-70150	6	21	of	of	ADP
ajbspi-70150	6	22	early	early	ADJ
ajbspi-70150	6	23	diagnosis	diagnosis	NOUN
ajbspi-70150	6	24	and	and	CCONJ
ajbspi-70150	6	25	targeted	target	VERB
ajbspi-70150	6	26	interventions	intervention	NOUN
ajbspi-70150	6	27	.	.	PUNCT
ajbspi-70150	7	1	keywords	keyword	NOUN
ajbspi-70150	7	2	:	:	PUNCT
ajbspi-70150	7	3	systemic	systemic	ADJ
ajbspi-70150	7	4	scleroderma	scleroderma	NOUN
ajbspi-70150	7	5	,	,	PUNCT
ajbspi-70150	7	6	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	7	7	,	,	PUNCT
ajbspi-70150	7	8	cardiovascular	cardiovascular	ADJ
ajbspi-70150	7	9	diseases	disease	NOUN
ajbspi-70150	7	10	,	,	PUNCT
ajbspi-70150	7	11	endothelial	endothelial	ADJ
ajbspi-70150	7	12	dysfunction	dysfunction	NOUN
ajbspi-70150	7	13	,	,	PUNCT
ajbspi-70150	7	14	lipid	lipid	NOUN
ajbspi-70150	7	15	abnormalities	abnormality	NOUN
ajbspi-70150	7	16	,	,	PUNCT
ajbspi-70150	7	17	autoimmune	autoimmune	ADJ
ajbspi-70150	7	18	diseases	disease	NOUN
ajbspi-70150	7	19	.	.	PUNCT
ajbspi-70150	8	1	introduction	introduction	NOUN
ajbspi-70150	8	2	:	:	PUNCT
ajbspi-70150	8	3	systemic	systemic	ADJ
ajbspi-70150	8	4	scleroderma	scleroderma	NOUN
ajbspi-70150	8	5	(	(	PUNCT
ajbspi-70150	8	6	ssc	ssc	NOUN
ajbspi-70150	8	7	)	)	PUNCT
ajbspi-70150	8	8	is	be	AUX
ajbspi-70150	8	9	a	a	DET
ajbspi-70150	8	10	systemic	systemic	ADJ
ajbspi-70150	8	11	autoimmune	autoimmune	ADJ
ajbspi-70150	8	12	disease	disease	NOUN
ajbspi-70150	8	13	that	that	PRON
ajbspi-70150	8	14	primarily	primarily	ADV
ajbspi-70150	8	15	affects	affect	VERB
ajbspi-70150	8	16	the	the	DET
ajbspi-70150	8	17	skin	skin	NOUN
ajbspi-70150	8	18	but	but	CCONJ
ajbspi-70150	8	19	can	can	AUX
ajbspi-70150	8	20	also	also	ADV
ajbspi-70150	8	21	involve	involve	VERB
ajbspi-70150	8	22	internal	internal	ADJ
ajbspi-70150	8	23	organs	organ	NOUN
ajbspi-70150	8	24	,	,	PUNCT
ajbspi-70150	8	25	including	include	VERB
ajbspi-70150	8	26	the	the	DET
ajbspi-70150	8	27	heart	heart	NOUN
ajbspi-70150	8	28	,	,	PUNCT
ajbspi-70150	8	29	lungs	lung	NOUN
ajbspi-70150	8	30	,	,	PUNCT
ajbspi-70150	8	31	kidneys	kidney	NOUN
ajbspi-70150	8	32	,	,	PUNCT
ajbspi-70150	8	33	and	and	CCONJ
ajbspi-70150	8	34	gastrointestinal	gastrointestinal	ADJ
ajbspi-70150	8	35	tract	tract	NOUN
ajbspi-70150	8	36	.	.	PUNCT
ajbspi-70150	9	1	vascular	vascular	ADJ
ajbspi-70150	9	2	involvement	involvement	NOUN
ajbspi-70150	9	3	is	be	AUX
ajbspi-70150	9	4	one	one	NUM
ajbspi-70150	9	5	of	of	ADP
ajbspi-70150	9	6	the	the	DET
ajbspi-70150	9	7	hallmark	hallmark	ADJ
ajbspi-70150	9	8	features	feature	NOUN
ajbspi-70150	9	9	of	of	ADP
ajbspi-70150	9	10	systemic	systemic	ADJ
ajbspi-70150	9	11	scleroderma	scleroderma	NOUN
ajbspi-70150	9	12	and	and	CCONJ
ajbspi-70150	9	13	is	be	AUX
ajbspi-70150	9	14	characterized	characterize	VERB
ajbspi-70150	9	15	by	by	ADP
ajbspi-70150	9	16	microvascular	microvascular	ADJ
ajbspi-70150	9	17	abnormalities	abnormality	NOUN
ajbspi-70150	9	18	,	,	PUNCT
ajbspi-70150	9	19	including	include	VERB
ajbspi-70150	9	20	vasospasm	vasospasm	NOUN
ajbspi-70150	9	21	,	,	PUNCT
ajbspi-70150	9	22	capillary	capillary	ADJ
ajbspi-70150	9	23	loss	loss	NOUN
ajbspi-70150	9	24	,	,	PUNCT
ajbspi-70150	9	25	and	and	CCONJ
ajbspi-70150	9	26	fibrosis	fibrosis	NOUN
ajbspi-70150	9	27	of	of	ADP
ajbspi-70150	9	28	the	the	DET
ajbspi-70150	9	29	blood	blood	NOUN
ajbspi-70150	9	30	vessels	vessel	NOUN
ajbspi-70150	9	31	[	[	X
ajbspi-70150	9	32	1	1	NUM
ajbspi-70150	9	33	]	]	PUNCT
ajbspi-70150	9	34	.	.	PUNCT
ajbspi-70150	10	1	while	while	SCONJ
ajbspi-70150	10	2	the	the	DET
ajbspi-70150	10	3	primary	primary	ADJ
ajbspi-70150	10	4	clinical	clinical	ADJ
ajbspi-70150	10	5	focus	focus	NOUN
ajbspi-70150	10	6	of	of	ADP
ajbspi-70150	10	7	systemic	systemic	ADJ
ajbspi-70150	10	8	scleroderma	scleroderma	NOUN
ajbspi-70150	10	9	has	have	AUX
ajbspi-70150	10	10	often	often	ADV
ajbspi-70150	10	11	been	be	AUX
ajbspi-70150	10	12	its	its	PRON
ajbspi-70150	10	13	fibrotic	fibrotic	ADJ
ajbspi-70150	10	14	aspects	aspect	NOUN
ajbspi-70150	10	15	,	,	PUNCT
ajbspi-70150	10	16	there	there	PRON
ajbspi-70150	10	17	is	be	VERB
ajbspi-70150	10	18	increasing	increase	VERB
ajbspi-70150	10	19	recognition	recognition	NOUN
ajbspi-70150	10	20	of	of	ADP
ajbspi-70150	10	21	the	the	DET
ajbspi-70150	10	22	heightened	heightened	ADJ
ajbspi-70150	10	23	risk	risk	NOUN
ajbspi-70150	10	24	of	of	ADP
ajbspi-70150	10	25	cardiovascular	cardiovascular	ADJ
ajbspi-70150	10	26	diseases	disease	NOUN
ajbspi-70150	10	27	(	(	PUNCT
ajbspi-70150	10	28	cvd	cvd	NOUN
ajbspi-70150	10	29	)	)	PUNCT
ajbspi-70150	10	30	in	in	ADP
ajbspi-70150	10	31	these	these	DET
ajbspi-70150	10	32	patients	patient	NOUN
ajbspi-70150	10	33	.	.	PUNCT
ajbspi-70150	11	1	specifically	specifically	ADV
ajbspi-70150	11	2	,	,	PUNCT
ajbspi-70150	11	3	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	11	4	,	,	PUNCT
ajbspi-70150	11	5	a	a	DET
ajbspi-70150	11	6	chronic	chronic	ADJ
ajbspi-70150	11	7	inflammatory	inflammatory	ADJ
ajbspi-70150	11	8	process	process	NOUN
ajbspi-70150	11	9	that	that	PRON
ajbspi-70150	11	10	results	result	VERB
ajbspi-70150	11	11	in	in	ADP
ajbspi-70150	11	12	the	the	DET
ajbspi-70150	11	13	accumulation	accumulation	NOUN
ajbspi-70150	11	14	of	of	ADP
ajbspi-70150	11	15	cholesterol	cholesterol	NOUN
ajbspi-70150	11	16	and	and	CCONJ
ajbspi-70150	11	17	other	other	ADJ
ajbspi-70150	11	18	materials	material	NOUN
ajbspi-70150	11	19	in	in	ADP
ajbspi-70150	11	20	arterial	arterial	ADJ
ajbspi-70150	11	21	walls	wall	NOUN
ajbspi-70150	11	22	,	,	PUNCT
ajbspi-70150	11	23	has	have	AUX
ajbspi-70150	11	24	become	become	VERB
ajbspi-70150	11	25	a	a	DET
ajbspi-70150	11	26	major	major	ADJ
ajbspi-70150	11	27	concern	concern	NOUN
ajbspi-70150	11	28	in	in	ADP
ajbspi-70150	11	29	the	the	DET
ajbspi-70150	11	30	management	management	NOUN
ajbspi-70150	11	31	of	of	ADP
ajbspi-70150	11	32	systemic	systemic	ADJ
ajbspi-70150	11	33	scleroderma	scleroderma	NOUN
ajbspi-70150	11	34	.	.	PUNCT
ajbspi-70150	12	1	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	12	2	in	in	ADP
ajbspi-70150	12	3	ssc	ssc	PROPN
ajbspi-70150	12	4	is	be	AUX
ajbspi-70150	12	5	a	a	DET
ajbspi-70150	12	6	multifactorial	multifactorial	ADJ
ajbspi-70150	12	7	process	process	NOUN
ajbspi-70150	12	8	influenced	influence	VERB
ajbspi-70150	12	9	by	by	ADP
ajbspi-70150	12	10	both	both	PRON
ajbspi-70150	12	11	the	the	DET
ajbspi-70150	12	12	diseasespecific	diseasespecific	NOUN
ajbspi-70150	12	13	mechanisms	mechanism	NOUN
ajbspi-70150	12	14	and	and	CCONJ
ajbspi-70150	12	15	traditional	traditional	ADJ
ajbspi-70150	12	16	cardiovascular	cardiovascular	ADJ
ajbspi-70150	12	17	risk	risk	NOUN
ajbspi-70150	12	18	factors	factor	NOUN
ajbspi-70150	12	19	[	[	X
ajbspi-70150	12	20	2,8	2,8	X
ajbspi-70150	12	21	]	]	PUNCT
ajbspi-70150	12	22	.	.	PUNCT
ajbspi-70150	13	1	the	the	DET
ajbspi-70150	13	2	pathophysiology	pathophysiology	NOUN
ajbspi-70150	13	3	of	of	ADP
ajbspi-70150	13	4	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	13	5	in	in	ADP
ajbspi-70150	13	6	systemic	systemic	ADJ
ajbspi-70150	13	7	scleroderma	scleroderma	NOUN
ajbspi-70150	13	8	is	be	AUX
ajbspi-70150	13	9	complex	complex	ADJ
ajbspi-70150	13	10	and	and	CCONJ
ajbspi-70150	13	11	involves	involve	VERB
ajbspi-70150	13	12	endothelial	endothelial	ADJ
ajbspi-70150	13	13	dysfunction	dysfunction	NOUN
ajbspi-70150	13	14	,	,	PUNCT
ajbspi-70150	13	15	inflammatory	inflammatory	ADJ
ajbspi-70150	13	16	mediators	mediator	NOUN
ajbspi-70150	13	17	,	,	PUNCT
ajbspi-70150	13	18	lipid	lipid	NOUN
ajbspi-70150	13	19	abnormalities	abnormality	NOUN
ajbspi-70150	13	20	,	,	PUNCT
ajbspi-70150	13	21	and	and	CCONJ
ajbspi-70150	13	22	changes	change	NOUN
ajbspi-70150	13	23	in	in	ADP
ajbspi-70150	13	24	the	the	DET
ajbspi-70150	13	25	vascular	vascular	ADJ
ajbspi-70150	13	26	smooth	smooth	ADJ
ajbspi-70150	13	27	muscle	muscle	NOUN
ajbspi-70150	13	28	.	.	PUNCT
ajbspi-70150	14	1	this	this	DET
ajbspi-70150	14	2	review	review	NOUN
ajbspi-70150	14	3	will	will	AUX
ajbspi-70150	14	4	examine	examine	VERB
ajbspi-70150	14	5	the	the	DET
ajbspi-70150	14	6	primary	primary	ADJ
ajbspi-70150	14	7	risk	risk	NOUN
ajbspi-70150	14	8	factors	factor	NOUN
ajbspi-70150	14	9	that	that	PRON
ajbspi-70150	14	10	predispose	predispose	VERB
ajbspi-70150	14	11	systemic	systemic	ADJ
ajbspi-70150	14	12	scleroderma	scleroderma	NOUN
ajbspi-70150	14	13	patients	patient	NOUN
ajbspi-70150	14	14	to	to	ADP
ajbspi-70150	14	15	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	14	16	and	and	CCONJ
ajbspi-70150	14	17	discuss	discuss	VERB
ajbspi-70150	14	18	their	their	PRON
ajbspi-70150	14	19	clinical	clinical	ADJ
ajbspi-70150	14	20	https://doi.org/10.37547/ajbspi/volume05issue02-05	https://doi.org/10.37547/ajbspi/volume05issue02-05	ADJ
ajbspi-70150	14	21	https://doi.org/10.37547/ajbspi/volume05issue02-05	https://doi.org/10.37547/ajbspi/volume05issue02-05	PROPN
ajbspi-70150	14	22	american	american	PROPN
ajbspi-70150	14	23	journal	journal	PROPN
ajbspi-70150	14	24	of	of	ADP
ajbspi-70150	14	25	applied	apply	VERB
ajbspi-70150	14	26	science	science	NOUN
ajbspi-70150	14	27	and	and	CCONJ
ajbspi-70150	14	28	technology	technology	NOUN
ajbspi-70150	14	29	18	18	NUM
ajbspi-70150	14	30	https://theusajournals.com/index.php/ajast	https://theusajournals.com/index.php/ajast	NOUN
ajbspi-70150	14	31	american	american	PROPN
ajbspi-70150	14	32	journal	journal	PROPN
ajbspi-70150	14	33	of	of	ADP
ajbspi-70150	14	34	applied	apply	VERB
ajbspi-70150	14	35	science	science	NOUN
ajbspi-70150	14	36	and	and	CCONJ
ajbspi-70150	14	37	technology	technology	NOUN
ajbspi-70150	14	38	(	(	PUNCT
ajbspi-70150	14	39	issn	issn	PROPN
ajbspi-70150	14	40	:	:	PUNCT
ajbspi-70150	14	41	2771	2771	NUM
ajbspi-70150	14	42	-	-	SYM
ajbspi-70150	14	43	2745	2745	NUM
ajbspi-70150	14	44	)	)	PUNCT
ajbspi-70150	14	45	implications	implication	NOUN
ajbspi-70150	14	46	.	.	PUNCT
ajbspi-70150	15	1	pathophysiology	pathophysiology	NOUN
ajbspi-70150	15	2	of	of	ADP
ajbspi-70150	15	3	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	15	4	in	in	ADP
ajbspi-70150	15	5	systemic	systemic	ADJ
ajbspi-70150	15	6	scleroderma	scleroderma	NOUN
ajbspi-70150	15	7	.	.	PUNCT
ajbspi-70150	16	1	the	the	DET
ajbspi-70150	16	2	pathogenesis	pathogenesis	NOUN
ajbspi-70150	16	3	of	of	ADP
ajbspi-70150	16	4	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	16	5	in	in	ADP
ajbspi-70150	16	6	systemic	systemic	ADJ
ajbspi-70150	16	7	scleroderma	scleroderma	NOUN
ajbspi-70150	16	8	involves	involve	VERB
ajbspi-70150	16	9	a	a	DET
ajbspi-70150	16	10	combination	combination	NOUN
ajbspi-70150	16	11	of	of	ADP
ajbspi-70150	16	12	endothelial	endothelial	ADJ
ajbspi-70150	16	13	dysfunction	dysfunction	NOUN
ajbspi-70150	16	14	,	,	PUNCT
ajbspi-70150	16	15	inflammation	inflammation	NOUN
ajbspi-70150	16	16	,	,	PUNCT
ajbspi-70150	16	17	and	and	CCONJ
ajbspi-70150	16	18	impaired	impaired	ADJ
ajbspi-70150	16	19	vascular	vascular	ADJ
ajbspi-70150	16	20	repair	repair	NOUN
ajbspi-70150	16	21	.	.	PUNCT
ajbspi-70150	17	1	in	in	ADP
ajbspi-70150	17	2	ssc	ssc	PROPN
ajbspi-70150	17	3	,	,	PUNCT
ajbspi-70150	17	4	vascular	vascular	ADJ
ajbspi-70150	17	5	injury	injury	NOUN
ajbspi-70150	17	6	occurs	occur	VERB
ajbspi-70150	17	7	due	due	ADJ
ajbspi-70150	17	8	to	to	ADP
ajbspi-70150	17	9	fibrosis	fibrosis	NOUN
ajbspi-70150	17	10	,	,	PUNCT
ajbspi-70150	17	11	immune	immune	ADJ
ajbspi-70150	17	12	cell	cell	NOUN
ajbspi-70150	17	13	activation	activation	NOUN
ajbspi-70150	17	14	,	,	PUNCT
ajbspi-70150	17	15	and	and	CCONJ
ajbspi-70150	17	16	chronic	chronic	ADJ
ajbspi-70150	17	17	inflammation	inflammation	NOUN
ajbspi-70150	17	18	.	.	PUNCT
ajbspi-70150	18	1	endothelial	endothelial	ADJ
ajbspi-70150	18	2	cells	cell	NOUN
ajbspi-70150	18	3	in	in	ADP
ajbspi-70150	18	4	patients	patient	NOUN
ajbspi-70150	18	5	with	with	ADP
ajbspi-70150	18	6	systemic	systemic	ADJ
ajbspi-70150	18	7	sclerosis	sclerosis	NOUN
ajbspi-70150	18	8	exhibit	exhibit	VERB
ajbspi-70150	18	9	increased	increase	VERB
ajbspi-70150	18	10	permeability	permeability	NOUN
ajbspi-70150	18	11	,	,	PUNCT
ajbspi-70150	18	12	decreased	decrease	VERB
ajbspi-70150	18	13	nitric	nitric	ADJ
ajbspi-70150	18	14	oxide	oxide	NOUN
ajbspi-70150	18	15	production	production	NOUN
ajbspi-70150	18	16	,	,	PUNCT
ajbspi-70150	18	17	and	and	CCONJ
ajbspi-70150	18	18	upregulation	upregulation	NOUN
ajbspi-70150	18	19	of	of	ADP
ajbspi-70150	18	20	adhesion	adhesion	NOUN
ajbspi-70150	18	21	molecules	molecule	NOUN
ajbspi-70150	18	22	,	,	PUNCT
ajbspi-70150	18	23	leading	lead	VERB
ajbspi-70150	18	24	to	to	ADP
ajbspi-70150	18	25	the	the	DET
ajbspi-70150	18	26	recruitment	recruitment	NOUN
ajbspi-70150	18	27	of	of	ADP
ajbspi-70150	18	28	inflammatory	inflammatory	ADJ
ajbspi-70150	18	29	cells	cell	NOUN
ajbspi-70150	18	30	[	[	X
ajbspi-70150	18	31	3	3	NUM
ajbspi-70150	18	32	]	]	PUNCT
ajbspi-70150	18	33	.	.	PUNCT
ajbspi-70150	19	1	this	this	PRON
ajbspi-70150	19	2	results	result	VERB
ajbspi-70150	19	3	in	in	ADP
ajbspi-70150	19	4	the	the	DET
ajbspi-70150	19	5	formation	formation	NOUN
ajbspi-70150	19	6	of	of	ADP
ajbspi-70150	19	7	an	an	DET
ajbspi-70150	19	8	atherosclerotic	atherosclerotic	ADJ
ajbspi-70150	19	9	plaque	plaque	NOUN
ajbspi-70150	19	10	,	,	PUNCT
ajbspi-70150	19	11	which	which	PRON
ajbspi-70150	19	12	may	may	AUX
ajbspi-70150	19	13	progress	progress	VERB
ajbspi-70150	19	14	more	more	ADV
ajbspi-70150	19	15	rapidly	rapidly	ADV
ajbspi-70150	19	16	due	due	ADP
ajbspi-70150	19	17	to	to	ADP
ajbspi-70150	19	18	the	the	DET
ajbspi-70150	19	19	vascular	vascular	ADJ
ajbspi-70150	19	20	abnormalities	abnormality	NOUN
ajbspi-70150	19	21	intrinsic	intrinsic	ADJ
ajbspi-70150	19	22	to	to	ADP
ajbspi-70150	19	23	systemic	systemic	ADJ
ajbspi-70150	19	24	scleroderma	scleroderma	NOUN
ajbspi-70150	19	25	.	.	PUNCT
ajbspi-70150	20	1	endothelial	endothelial	ADJ
ajbspi-70150	20	2	dysfunction	dysfunction	NOUN
ajbspi-70150	20	3	and	and	CCONJ
ajbspi-70150	20	4	microvascular	microvascular	ADJ
ajbspi-70150	20	5	injury	injury	NOUN
ajbspi-70150	20	6	.	.	PUNCT
ajbspi-70150	21	1	endothelial	endothelial	ADJ
ajbspi-70150	21	2	dysfunction	dysfunction	NOUN
ajbspi-70150	21	3	is	be	AUX
ajbspi-70150	21	4	a	a	DET
ajbspi-70150	21	5	critical	critical	ADJ
ajbspi-70150	21	6	early	early	ADJ
ajbspi-70150	21	7	event	event	NOUN
ajbspi-70150	21	8	in	in	ADP
ajbspi-70150	21	9	the	the	DET
ajbspi-70150	21	10	pathogenesis	pathogenesis	NOUN
ajbspi-70150	21	11	of	of	ADP
ajbspi-70150	21	12	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	21	13	,	,	PUNCT
ajbspi-70150	21	14	and	and	CCONJ
ajbspi-70150	21	15	it	it	PRON
ajbspi-70150	21	16	is	be	AUX
ajbspi-70150	21	17	exacerbated	exacerbate	VERB
ajbspi-70150	21	18	in	in	ADP
ajbspi-70150	21	19	systemic	systemic	ADJ
ajbspi-70150	21	20	scleroderma	scleroderma	NOUN
ajbspi-70150	21	21	due	due	ADP
ajbspi-70150	21	22	to	to	ADP
ajbspi-70150	21	23	microvascular	microvascular	ADJ
ajbspi-70150	21	24	damage	damage	NOUN
ajbspi-70150	21	25	.	.	PUNCT
ajbspi-70150	22	1	in	in	ADP
ajbspi-70150	22	2	ssc	ssc	PROPN
ajbspi-70150	22	3	,	,	PUNCT
ajbspi-70150	22	4	endothelial	endothelial	ADJ
ajbspi-70150	22	5	cells	cell	NOUN
ajbspi-70150	22	6	are	be	AUX
ajbspi-70150	22	7	injured	injure	VERB
ajbspi-70150	22	8	by	by	ADP
ajbspi-70150	22	9	both	both	DET
ajbspi-70150	22	10	mechanical	mechanical	ADJ
ajbspi-70150	22	11	forces	force	NOUN
ajbspi-70150	22	12	,	,	PUNCT
ajbspi-70150	22	13	such	such	ADJ
ajbspi-70150	22	14	as	as	ADP
ajbspi-70150	22	15	shear	shear	NOUN
ajbspi-70150	22	16	stress	stress	NOUN
ajbspi-70150	22	17	from	from	ADP
ajbspi-70150	22	18	blood	blood	NOUN
ajbspi-70150	22	19	flow	flow	NOUN
ajbspi-70150	22	20	,	,	PUNCT
ajbspi-70150	22	21	and	and	CCONJ
ajbspi-70150	22	22	by	by	ADP
ajbspi-70150	22	23	inflammatory	inflammatory	ADJ
ajbspi-70150	22	24	mediators	mediator	NOUN
ajbspi-70150	22	25	.	.	PUNCT
ajbspi-70150	23	1	the	the	DET
ajbspi-70150	23	2	presence	presence	NOUN
ajbspi-70150	23	3	of	of	ADP
ajbspi-70150	23	4	raynaud	raynaud	PROPN
ajbspi-70150	23	5	's	's	PART
ajbspi-70150	23	6	phenomenon	phenomenon	NOUN
ajbspi-70150	23	7	,	,	PUNCT
ajbspi-70150	23	8	a	a	DET
ajbspi-70150	23	9	characteristic	characteristic	ADJ
ajbspi-70150	23	10	feature	feature	NOUN
ajbspi-70150	23	11	of	of	ADP
ajbspi-70150	23	12	systemic	systemic	ADJ
ajbspi-70150	23	13	scleroderma	scleroderma	NOUN
ajbspi-70150	23	14	,	,	PUNCT
ajbspi-70150	23	15	can	can	AUX
ajbspi-70150	23	16	further	far	ADV
ajbspi-70150	23	17	damage	damage	VERB
ajbspi-70150	23	18	the	the	DET
ajbspi-70150	23	19	endothelium	endothelium	NOUN
ajbspi-70150	23	20	by	by	ADP
ajbspi-70150	23	21	causing	cause	VERB
ajbspi-70150	23	22	periodic	periodic	ADJ
ajbspi-70150	23	23	ischemia	ischemia	NOUN
ajbspi-70150	23	24	and	and	CCONJ
ajbspi-70150	23	25	reperfusion	reperfusion	NOUN
ajbspi-70150	23	26	injury	injury	NOUN
ajbspi-70150	23	27	.	.	PUNCT
ajbspi-70150	24	1	over	over	ADP
ajbspi-70150	24	2	time	time	NOUN
ajbspi-70150	24	3	,	,	PUNCT
ajbspi-70150	24	4	endothelial	endothelial	ADJ
ajbspi-70150	24	5	cells	cell	NOUN
ajbspi-70150	24	6	lose	lose	VERB
ajbspi-70150	24	7	their	their	PRON
ajbspi-70150	24	8	ability	ability	NOUN
ajbspi-70150	24	9	to	to	PART
ajbspi-70150	24	10	maintain	maintain	VERB
ajbspi-70150	24	11	vascular	vascular	ADJ
ajbspi-70150	24	12	tone	tone	NOUN
ajbspi-70150	24	13	and	and	CCONJ
ajbspi-70150	24	14	promote	promote	VERB
ajbspi-70150	24	15	vasodilation	vasodilation	NOUN
ajbspi-70150	24	16	,	,	PUNCT
ajbspi-70150	24	17	contributing	contribute	VERB
ajbspi-70150	24	18	to	to	ADP
ajbspi-70150	24	19	the	the	DET
ajbspi-70150	24	20	progression	progression	NOUN
ajbspi-70150	24	21	of	of	ADP
ajbspi-70150	24	22	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	24	23	[	[	X
ajbspi-70150	24	24	4	4	NUM
ajbspi-70150	24	25	]	]	PUNCT
ajbspi-70150	24	26	.	.	PUNCT
ajbspi-70150	25	1	chronic	chronic	ADJ
ajbspi-70150	25	2	inflammation	inflammation	NOUN
ajbspi-70150	25	3	and	and	CCONJ
ajbspi-70150	25	4	immune	immune	ADJ
ajbspi-70150	25	5	activation	activation	NOUN
ajbspi-70150	25	6	.	.	PUNCT
ajbspi-70150	26	1	chronic	chronic	ADJ
ajbspi-70150	26	2	inflammation	inflammation	NOUN
ajbspi-70150	26	3	plays	play	VERB
ajbspi-70150	26	4	a	a	DET
ajbspi-70150	26	5	pivotal	pivotal	ADJ
ajbspi-70150	26	6	role	role	NOUN
ajbspi-70150	26	7	in	in	ADP
ajbspi-70150	26	8	the	the	DET
ajbspi-70150	26	9	development	development	NOUN
ajbspi-70150	26	10	of	of	ADP
ajbspi-70150	26	11	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	26	12	in	in	ADP
ajbspi-70150	26	13	patients	patient	NOUN
ajbspi-70150	26	14	with	with	ADP
ajbspi-70150	26	15	systemic	systemic	ADJ
ajbspi-70150	26	16	scleroderma	scleroderma	NOUN
ajbspi-70150	26	17	.	.	PUNCT
ajbspi-70150	27	1	elevated	elevated	ADJ
ajbspi-70150	27	2	levels	level	NOUN
ajbspi-70150	27	3	of	of	ADP
ajbspi-70150	27	4	proinflammatory	proinflammatory	ADJ
ajbspi-70150	27	5	cytokines	cytokine	NOUN
ajbspi-70150	27	6	,	,	PUNCT
ajbspi-70150	27	7	including	include	VERB
ajbspi-70150	27	8	tumor	tumor	NOUN
ajbspi-70150	27	9	necrosis	necrosis	NOUN
ajbspi-70150	27	10	factor	factor	NOUN
ajbspi-70150	27	11	-	-	PUNCT
ajbspi-70150	27	12	alpha	alpha	NOUN
ajbspi-70150	27	13	(	(	PUNCT
ajbspi-70150	27	14	tnf	tnf	PROPN
ajbspi-70150	27	15	-	-	PUNCT
ajbspi-70150	27	16	α	α	NOUN
ajbspi-70150	27	17	)	)	PUNCT
ajbspi-70150	27	18	,	,	PUNCT
ajbspi-70150	27	19	interleukin-6	interleukin-6	PROPN
ajbspi-70150	27	20	(	(	PUNCT
ajbspi-70150	27	21	il-6	il-6	NUM
ajbspi-70150	27	22	)	)	PUNCT
ajbspi-70150	27	23	,	,	PUNCT
ajbspi-70150	27	24	and	and	CCONJ
ajbspi-70150	27	25	interleukin-1β	interleukin-1β	X
ajbspi-70150	27	26	(	(	PUNCT
ajbspi-70150	27	27	il-1β	il-1β	PROPN
ajbspi-70150	27	28	)	)	PUNCT
ajbspi-70150	27	29	,	,	PUNCT
ajbspi-70150	27	30	are	be	AUX
ajbspi-70150	27	31	frequently	frequently	ADV
ajbspi-70150	27	32	observed	observe	VERB
ajbspi-70150	27	33	in	in	ADP
ajbspi-70150	27	34	patients	patient	NOUN
ajbspi-70150	27	35	with	with	ADP
ajbspi-70150	27	36	ssc	ssc	PROPN
ajbspi-70150	27	37	.	.	PUNCT
ajbspi-70150	28	1	these	these	DET
ajbspi-70150	28	2	inflammatory	inflammatory	ADJ
ajbspi-70150	28	3	cytokines	cytokine	NOUN
ajbspi-70150	28	4	promote	promote	VERB
ajbspi-70150	28	5	the	the	DET
ajbspi-70150	28	6	activation	activation	NOUN
ajbspi-70150	28	7	of	of	ADP
ajbspi-70150	28	8	endothelial	endothelial	ADJ
ajbspi-70150	28	9	cells	cell	NOUN
ajbspi-70150	28	10	,	,	PUNCT
ajbspi-70150	28	11	the	the	DET
ajbspi-70150	28	12	infiltration	infiltration	NOUN
ajbspi-70150	28	13	of	of	ADP
ajbspi-70150	28	14	monocytes	monocyte	NOUN
ajbspi-70150	28	15	into	into	ADP
ajbspi-70150	28	16	the	the	DET
ajbspi-70150	28	17	arterial	arterial	ADJ
ajbspi-70150	28	18	wall	wall	NOUN
ajbspi-70150	28	19	,	,	PUNCT
ajbspi-70150	28	20	and	and	CCONJ
ajbspi-70150	28	21	the	the	DET
ajbspi-70150	28	22	formation	formation	NOUN
ajbspi-70150	28	23	of	of	ADP
ajbspi-70150	28	24	foam	foam	NOUN
ajbspi-70150	28	25	cells	cell	NOUN
ajbspi-70150	28	26	,	,	PUNCT
ajbspi-70150	28	27	all	all	PRON
ajbspi-70150	28	28	of	of	ADP
ajbspi-70150	28	29	which	which	PRON
ajbspi-70150	28	30	contribute	contribute	VERB
ajbspi-70150	28	31	to	to	ADP
ajbspi-70150	28	32	plaque	plaque	NOUN
ajbspi-70150	28	33	formation	formation	NOUN
ajbspi-70150	28	34	.	.	PUNCT
ajbspi-70150	29	1	additionally	additionally	ADV
ajbspi-70150	29	2	,	,	PUNCT
ajbspi-70150	29	3	autoantibodies	autoantibody	NOUN
ajbspi-70150	29	4	commonly	commonly	ADV
ajbspi-70150	29	5	present	present	ADJ
ajbspi-70150	29	6	in	in	ADP
ajbspi-70150	29	7	ssc	ssc	PROPN
ajbspi-70150	29	8	,	,	PUNCT
ajbspi-70150	29	9	such	such	ADJ
ajbspi-70150	29	10	as	as	ADP
ajbspi-70150	29	11	anti	anti	ADJ
ajbspi-70150	29	12	-	-	ADJ
ajbspi-70150	29	13	centromere	centromere	ADJ
ajbspi-70150	29	14	and	and	CCONJ
ajbspi-70150	29	15	anti	anti	ADJ
ajbspi-70150	29	16	-	-	ADJ
ajbspi-70150	29	17	topoisomerase	topoisomerase	ADJ
ajbspi-70150	29	18	i	i	PRON
ajbspi-70150	29	19	antibodies	antibodie	VERB
ajbspi-70150	29	20	,	,	PUNCT
ajbspi-70150	29	21	may	may	AUX
ajbspi-70150	29	22	directly	directly	ADV
ajbspi-70150	29	23	contribute	contribute	VERB
ajbspi-70150	29	24	to	to	ADP
ajbspi-70150	29	25	vascular	vascular	ADJ
ajbspi-70150	29	26	damage	damage	NOUN
ajbspi-70150	29	27	and	and	CCONJ
ajbspi-70150	29	28	accelerate	accelerate	VERB
ajbspi-70150	29	29	atherosclerotic	atherosclerotic	ADJ
ajbspi-70150	29	30	progression	progression	NOUN
ajbspi-70150	29	31	through	through	ADP
ajbspi-70150	29	32	immune	immune	ADJ
ajbspi-70150	29	33	complex	complex	ADJ
ajbspi-70150	29	34	deposition	deposition	NOUN
ajbspi-70150	29	35	and	and	CCONJ
ajbspi-70150	29	36	subsequent	subsequent	ADJ
ajbspi-70150	29	37	tissue	tissue	NOUN
ajbspi-70150	29	38	injury	injury	NOUN
ajbspi-70150	29	39	.	.	PUNCT
ajbspi-70150	30	1	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	30	2	and	and	CCONJ
ajbspi-70150	30	3	lipid	lipid	ADJ
ajbspi-70150	30	4	metabolism	metabolism	NOUN
ajbspi-70150	30	5	.	.	PUNCT
ajbspi-70150	31	1	alterations	alteration	NOUN
ajbspi-70150	31	2	in	in	ADP
ajbspi-70150	31	3	lipid	lipid	ADJ
ajbspi-70150	31	4	metabolism	metabolism	NOUN
ajbspi-70150	31	5	are	be	AUX
ajbspi-70150	31	6	common	common	ADJ
ajbspi-70150	31	7	in	in	ADP
ajbspi-70150	31	8	systemic	systemic	ADJ
ajbspi-70150	31	9	scleroderma	scleroderma	NOUN
ajbspi-70150	31	10	and	and	CCONJ
ajbspi-70150	31	11	represent	represent	VERB
ajbspi-70150	31	12	a	a	DET
ajbspi-70150	31	13	significant	significant	ADJ
ajbspi-70150	31	14	risk	risk	NOUN
ajbspi-70150	31	15	factor	factor	NOUN
ajbspi-70150	31	16	for	for	ADP
ajbspi-70150	31	17	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	31	18	.	.	PUNCT
ajbspi-70150	32	1	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	32	2	in	in	ADP
ajbspi-70150	32	3	ssc	ssc	NOUN
ajbspi-70150	32	4	is	be	AUX
ajbspi-70150	32	5	characterized	characterize	VERB
ajbspi-70150	32	6	by	by	ADP
ajbspi-70150	32	7	low	low	ADJ
ajbspi-70150	32	8	levels	level	NOUN
ajbspi-70150	32	9	of	of	ADP
ajbspi-70150	32	10	high	high	ADJ
ajbspi-70150	32	11	-	-	PUNCT
ajbspi-70150	32	12	density	density	NOUN
ajbspi-70150	32	13	lipoprotein	lipoprotein	ADJ
ajbspi-70150	32	14	(	(	PUNCT
ajbspi-70150	32	15	hdl	hdl	NOUN
ajbspi-70150	32	16	)	)	PUNCT
ajbspi-70150	32	17	cholesterol	cholesterol	NOUN
ajbspi-70150	32	18	,	,	PUNCT
ajbspi-70150	32	19	which	which	PRON
ajbspi-70150	32	20	has	have	VERB
ajbspi-70150	32	21	a	a	DET
ajbspi-70150	32	22	protective	protective	ADJ
ajbspi-70150	32	23	effect	effect	NOUN
ajbspi-70150	32	24	on	on	ADP
ajbspi-70150	32	25	endothelial	endothelial	ADJ
ajbspi-70150	32	26	function	function	NOUN
ajbspi-70150	32	27	,	,	PUNCT
ajbspi-70150	32	28	and	and	CCONJ
ajbspi-70150	32	29	elevated	elevated	ADJ
ajbspi-70150	32	30	levels	level	NOUN
ajbspi-70150	32	31	of	of	ADP
ajbspi-70150	32	32	low	low	ADJ
ajbspi-70150	32	33	-	-	PUNCT
ajbspi-70150	32	34	density	density	NOUN
ajbspi-70150	32	35	lipoprotein	lipoprotein	ADJ
ajbspi-70150	32	36	(	(	PUNCT
ajbspi-70150	32	37	ldl	ldl	NOUN
ajbspi-70150	32	38	)	)	PUNCT
ajbspi-70150	32	39	cholesterol	cholesterol	NOUN
ajbspi-70150	32	40	and	and	CCONJ
ajbspi-70150	32	41	triglycerides	triglyceride	NOUN
ajbspi-70150	32	42	,	,	PUNCT
ajbspi-70150	32	43	both	both	PRON
ajbspi-70150	32	44	of	of	ADP
ajbspi-70150	32	45	which	which	PRON
ajbspi-70150	32	46	promote	promote	VERB
ajbspi-70150	32	47	the	the	DET
ajbspi-70150	32	48	formation	formation	NOUN
ajbspi-70150	32	49	of	of	ADP
ajbspi-70150	32	50	atherosclerotic	atherosclerotic	ADJ
ajbspi-70150	32	51	plaques	plaque	NOUN
ajbspi-70150	32	52	.	.	PUNCT
ajbspi-70150	33	1	the	the	DET
ajbspi-70150	33	2	mechanisms	mechanism	NOUN
ajbspi-70150	33	3	underlying	underlie	VERB
ajbspi-70150	33	4	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	33	5	in	in	ADP
ajbspi-70150	33	6	ssc	ssc	NOUN
ajbspi-70150	33	7	are	be	AUX
ajbspi-70150	33	8	complex	complex	ADJ
ajbspi-70150	33	9	and	and	CCONJ
ajbspi-70150	33	10	involve	involve	VERB
ajbspi-70150	33	11	altered	alter	VERB
ajbspi-70150	33	12	lipid	lipid	NOUN
ajbspi-70150	33	13	synthesis	synthesis	NOUN
ajbspi-70150	33	14	,	,	PUNCT
ajbspi-70150	33	15	oxidative	oxidative	ADJ
ajbspi-70150	33	16	stress	stress	NOUN
ajbspi-70150	33	17	,	,	PUNCT
ajbspi-70150	33	18	and	and	CCONJ
ajbspi-70150	33	19	inflammation	inflammation	NOUN
ajbspi-70150	33	20	[	[	X
ajbspi-70150	33	21	5,11	5,11	NUM
ajbspi-70150	33	22	]	]	X
ajbspi-70150	33	23	.	.	PUNCT
ajbspi-70150	34	1	this	this	DET
ajbspi-70150	34	2	dyslipidemic	dyslipidemic	ADJ
ajbspi-70150	34	3	profile	profile	NOUN
ajbspi-70150	34	4	increases	increase	VERB
ajbspi-70150	34	5	the	the	DET
ajbspi-70150	34	6	likelihood	likelihood	NOUN
ajbspi-70150	34	7	of	of	ADP
ajbspi-70150	34	8	lipid	lipid	ADJ
ajbspi-70150	34	9	deposition	deposition	NOUN
ajbspi-70150	34	10	in	in	ADP
ajbspi-70150	34	11	the	the	DET
ajbspi-70150	34	12	arterial	arterial	ADJ
ajbspi-70150	34	13	walls	wall	NOUN
ajbspi-70150	34	14	,	,	PUNCT
ajbspi-70150	34	15	thereby	thereby	ADV
ajbspi-70150	34	16	fostering	foster	VERB
ajbspi-70150	34	17	the	the	DET
ajbspi-70150	34	18	development	development	NOUN
ajbspi-70150	34	19	of	of	ADP
ajbspi-70150	34	20	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	34	21	.	.	PUNCT
ajbspi-70150	35	1	hypertension	hypertension	NOUN
ajbspi-70150	35	2	.	.	PUNCT
ajbspi-70150	36	1	hypertension	hypertension	NOUN
ajbspi-70150	36	2	is	be	AUX
ajbspi-70150	36	3	a	a	DET
ajbspi-70150	36	4	common	common	ADJ
ajbspi-70150	36	5	comorbidity	comorbidity	NOUN
ajbspi-70150	36	6	in	in	ADP
ajbspi-70150	36	7	patients	patient	NOUN
ajbspi-70150	36	8	with	with	ADP
ajbspi-70150	36	9	systemic	systemic	ADJ
ajbspi-70150	36	10	scleroderma	scleroderma	NOUN
ajbspi-70150	36	11	and	and	CCONJ
ajbspi-70150	36	12	significantly	significantly	ADV
ajbspi-70150	36	13	increases	increase	VERB
ajbspi-70150	36	14	the	the	DET
ajbspi-70150	36	15	risk	risk	NOUN
ajbspi-70150	36	16	of	of	ADP
ajbspi-70150	36	17	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	36	18	.	.	PUNCT
ajbspi-70150	37	1	renal	renal	ADJ
ajbspi-70150	37	2	involvement	involvement	NOUN
ajbspi-70150	37	3	in	in	ADP
ajbspi-70150	37	4	ssc	ssc	PROPN
ajbspi-70150	37	5	,	,	PUNCT
ajbspi-70150	37	6	including	include	VERB
ajbspi-70150	37	7	scleroderma	scleroderma	PROPN
ajbspi-70150	37	8	renal	renal	ADJ
ajbspi-70150	37	9	crisis	crisis	NOUN
ajbspi-70150	37	10	,	,	PUNCT
ajbspi-70150	37	11	can	can	AUX
ajbspi-70150	37	12	lead	lead	VERB
ajbspi-70150	37	13	to	to	ADP
ajbspi-70150	37	14	secondary	secondary	ADJ
ajbspi-70150	37	15	hypertension	hypertension	NOUN
ajbspi-70150	37	16	,	,	PUNCT
ajbspi-70150	37	17	which	which	PRON
ajbspi-70150	37	18	accelerates	accelerate	VERB
ajbspi-70150	37	19	the	the	DET
ajbspi-70150	37	20	progression	progression	NOUN
ajbspi-70150	37	21	of	of	ADP
ajbspi-70150	37	22	vascular	vascular	ADJ
ajbspi-70150	37	23	damage	damage	NOUN
ajbspi-70150	37	24	.	.	PUNCT
ajbspi-70150	38	1	furthermore	furthermore	ADV
ajbspi-70150	38	2	,	,	PUNCT
ajbspi-70150	38	3	the	the	DET
ajbspi-70150	38	4	use	use	NOUN
ajbspi-70150	38	5	of	of	ADP
ajbspi-70150	38	6	corticosteroids	corticosteroid	NOUN
ajbspi-70150	38	7	in	in	ADP
ajbspi-70150	38	8	ssc	ssc	NOUN
ajbspi-70150	38	9	treatment	treatment	NOUN
ajbspi-70150	38	10	may	may	AUX
ajbspi-70150	38	11	also	also	ADV
ajbspi-70150	38	12	contribute	contribute	VERB
ajbspi-70150	38	13	to	to	ADP
ajbspi-70150	38	14	elevated	elevated	ADJ
ajbspi-70150	38	15	blood	blood	NOUN
ajbspi-70150	38	16	pressure	pressure	NOUN
ajbspi-70150	38	17	.	.	PUNCT
ajbspi-70150	39	1	hypertension	hypertension	NOUN
ajbspi-70150	39	2	induces	induce	VERB
ajbspi-70150	39	3	mechanical	mechanical	ADJ
ajbspi-70150	39	4	stress	stress	NOUN
ajbspi-70150	39	5	on	on	ADP
ajbspi-70150	39	6	the	the	DET
ajbspi-70150	39	7	endothelial	endothelial	ADJ
ajbspi-70150	39	8	cells	cell	NOUN
ajbspi-70150	39	9	,	,	PUNCT
ajbspi-70150	39	10	enhances	enhance	VERB
ajbspi-70150	39	11	inflammation	inflammation	NOUN
ajbspi-70150	39	12	,	,	PUNCT
ajbspi-70150	39	13	and	and	CCONJ
ajbspi-70150	39	14	promotes	promote	VERB
ajbspi-70150	39	15	plaque	plaque	NOUN
ajbspi-70150	39	16	instability	instability	NOUN
ajbspi-70150	39	17	,	,	PUNCT
ajbspi-70150	39	18	all	all	PRON
ajbspi-70150	39	19	of	of	ADP
ajbspi-70150	39	20	which	which	PRON
ajbspi-70150	39	21	facilitate	facilitate	VERB
ajbspi-70150	39	22	the	the	DET
ajbspi-70150	39	23	development	development	NOUN
ajbspi-70150	39	24	of	of	ADP
ajbspi-70150	39	25	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	39	26	.	.	PUNCT
ajbspi-70150	40	1	immune	immune	ADJ
ajbspi-70150	40	2	system	system	NOUN
ajbspi-70150	40	3	dysfunction	dysfunction	NOUN
ajbspi-70150	40	4	and	and	CCONJ
ajbspi-70150	40	5	autoimmunity	autoimmunity	NOUN
ajbspi-70150	40	6	.	.	PUNCT
ajbspi-70150	41	1	the	the	DET
ajbspi-70150	41	2	autoimmune	autoimmune	ADJ
ajbspi-70150	41	3	nature	nature	NOUN
ajbspi-70150	41	4	of	of	ADP
ajbspi-70150	41	5	systemic	systemic	ADJ
ajbspi-70150	41	6	scleroderma	scleroderma	NOUN
ajbspi-70150	41	7	predisposes	predispose	NOUN
ajbspi-70150	41	8	patients	patient	NOUN
ajbspi-70150	41	9	to	to	ADP
ajbspi-70150	41	10	abnormal	abnormal	ADJ
ajbspi-70150	41	11	immune	immune	ADJ
ajbspi-70150	41	12	responses	response	NOUN
ajbspi-70150	41	13	that	that	PRON
ajbspi-70150	41	14	can	can	AUX
ajbspi-70150	41	15	exacerbate	exacerbate	VERB
ajbspi-70150	41	16	vascular	vascular	ADJ
ajbspi-70150	41	17	injury	injury	NOUN
ajbspi-70150	41	18	.	.	PUNCT
ajbspi-70150	42	1	the	the	DET
ajbspi-70150	42	2	presence	presence	NOUN
ajbspi-70150	42	3	of	of	ADP
ajbspi-70150	42	4	specific	specific	ADJ
ajbspi-70150	42	5	autoantibodies	autoantibody	NOUN
ajbspi-70150	42	6	in	in	ADP
ajbspi-70150	42	7	ssc	ssc	PROPN
ajbspi-70150	42	8	,	,	PUNCT
ajbspi-70150	42	9	such	such	ADJ
ajbspi-70150	42	10	as	as	ADP
ajbspi-70150	42	11	anti	anti	ADJ
ajbspi-70150	42	12	-	-	ADJ
ajbspi-70150	42	13	scl-70	scl-70	PRON
ajbspi-70150	42	14	(	(	PUNCT
ajbspi-70150	42	15	topoisomerase	topoisomerase	NOUN
ajbspi-70150	42	16	i	i	NOUN
ajbspi-70150	42	17	)	)	PUNCT
ajbspi-70150	42	18	,	,	PUNCT
ajbspi-70150	42	19	can	can	AUX
ajbspi-70150	42	20	lead	lead	VERB
ajbspi-70150	42	21	to	to	ADP
ajbspi-70150	42	22	endothelial	endothelial	ADJ
ajbspi-70150	42	23	cell	cell	NOUN
ajbspi-70150	42	24	dysfunction	dysfunction	NOUN
ajbspi-70150	42	25	and	and	CCONJ
ajbspi-70150	42	26	the	the	DET
ajbspi-70150	42	27	promotion	promotion	NOUN
ajbspi-70150	42	28	of	of	ADP
ajbspi-70150	42	29	vascular	vascular	ADJ
ajbspi-70150	42	30	remodeling	remodeling	NOUN
ajbspi-70150	42	31	.	.	PUNCT
ajbspi-70150	43	1	additionally	additionally	ADV
ajbspi-70150	43	2	,	,	PUNCT
ajbspi-70150	43	3	circulating	circulating	ADJ
ajbspi-70150	43	4	immune	immune	ADJ
ajbspi-70150	43	5	complexes	complex	NOUN
ajbspi-70150	43	6	can	can	AUX
ajbspi-70150	43	7	deposit	deposit	VERB
ajbspi-70150	43	8	in	in	ADP
ajbspi-70150	43	9	the	the	DET
ajbspi-70150	43	10	blood	blood	NOUN
ajbspi-70150	43	11	vessel	vessel	NOUN
ajbspi-70150	43	12	walls	wall	NOUN
ajbspi-70150	43	13	,	,	PUNCT
ajbspi-70150	43	14	activating	activate	VERB
ajbspi-70150	43	15	complement	complement	NOUN
ajbspi-70150	43	16	and	and	CCONJ
ajbspi-70150	43	17	contributing	contribute	VERB
ajbspi-70150	43	18	to	to	ADP
ajbspi-70150	43	19	the	the	DET
ajbspi-70150	43	20	inflammatory	inflammatory	ADJ
ajbspi-70150	43	21	process	process	NOUN
ajbspi-70150	43	22	that	that	PRON
ajbspi-70150	43	23	drives	drive	VERB
ajbspi-70150	43	24	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	43	25	.	.	PUNCT
ajbspi-70150	44	1	the	the	DET
ajbspi-70150	44	2	immunemediated	immunemediate	VERB
ajbspi-70150	44	3	vascular	vascular	ADJ
ajbspi-70150	44	4	injury	injury	NOUN
ajbspi-70150	44	5	may	may	AUX
ajbspi-70150	44	6	be	be	AUX
ajbspi-70150	44	7	exacerbated	exacerbate	VERB
ajbspi-70150	44	8	by	by	ADP
ajbspi-70150	44	9	concomitant	concomitant	ADJ
ajbspi-70150	44	10	diseases	disease	NOUN
ajbspi-70150	44	11	,	,	PUNCT
ajbspi-70150	44	12	such	such	ADJ
ajbspi-70150	44	13	as	as	ADP
ajbspi-70150	44	14	lupus	lupus	NOUN
ajbspi-70150	44	15	or	or	CCONJ
ajbspi-70150	44	16	rheumatoid	rheumatoid	VERB
ajbspi-70150	44	17	arthritis	arthritis	NOUN
ajbspi-70150	44	18	,	,	PUNCT
ajbspi-70150	44	19	which	which	PRON
ajbspi-70150	44	20	are	be	AUX
ajbspi-70150	44	21	commonly	commonly	ADV
ajbspi-70150	44	22	associated	associate	VERB
ajbspi-70150	44	23	with	with	ADP
ajbspi-70150	44	24	systemic	systemic	ADJ
ajbspi-70150	44	25	scleroderma	scleroderma	NOUN
ajbspi-70150	44	26	.	.	PUNCT
ajbspi-70150	45	1	age	age	NOUN
ajbspi-70150	45	2	and	and	CCONJ
ajbspi-70150	45	3	gender	gender	NOUN
ajbspi-70150	45	4	.	.	PUNCT
ajbspi-70150	46	1	age	age	NOUN
ajbspi-70150	46	2	is	be	AUX
ajbspi-70150	46	3	a	a	DET
ajbspi-70150	46	4	well	well	ADV
ajbspi-70150	46	5	-	-	PUNCT
ajbspi-70150	46	6	established	establish	VERB
ajbspi-70150	46	7	risk	risk	NOUN
ajbspi-70150	46	8	factor	factor	NOUN
ajbspi-70150	46	9	for	for	ADP
ajbspi-70150	46	10	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	46	11	,	,	PUNCT
ajbspi-70150	46	12	and	and	CCONJ
ajbspi-70150	46	13	it	it	PRON
ajbspi-70150	46	14	remains	remain	VERB
ajbspi-70150	46	15	relevant	relevant	ADJ
ajbspi-70150	46	16	in	in	ADP
ajbspi-70150	46	17	patients	patient	NOUN
ajbspi-70150	46	18	with	with	ADP
ajbspi-70150	46	19	systemic	systemic	ADJ
ajbspi-70150	46	20	scleroderma	scleroderma	NOUN
ajbspi-70150	46	21	.	.	PUNCT
ajbspi-70150	47	1	the	the	DET
ajbspi-70150	47	2	risk	risk	NOUN
ajbspi-70150	47	3	of	of	ADP
ajbspi-70150	47	4	cardiovascular	cardiovascular	ADJ
ajbspi-70150	47	5	disease	disease	NOUN
ajbspi-70150	47	6	increases	increase	VERB
ajbspi-70150	47	7	with	with	ADP
ajbspi-70150	47	8	age	age	NOUN
ajbspi-70150	47	9	,	,	PUNCT
ajbspi-70150	47	10	as	as	SCONJ
ajbspi-70150	47	11	the	the	DET
ajbspi-70150	47	12	natural	natural	ADJ
ajbspi-70150	47	13	process	process	NOUN
ajbspi-70150	47	14	of	of	ADP
ajbspi-70150	47	15	vascular	vascular	ADJ
ajbspi-70150	47	16	aging	aging	NOUN
ajbspi-70150	47	17	contributes	contribute	VERB
ajbspi-70150	47	18	to	to	ADP
ajbspi-70150	47	19	endothelial	endothelial	ADJ
ajbspi-70150	47	20	dysfunction	dysfunction	NOUN
ajbspi-70150	47	21	and	and	CCONJ
ajbspi-70150	47	22	plaque	plaque	NOUN
ajbspi-70150	47	23	formation	formation	NOUN
ajbspi-70150	47	24	.	.	PUNCT
ajbspi-70150	48	1	gender	gender	NOUN
ajbspi-70150	48	2	differences	difference	NOUN
ajbspi-70150	48	3	also	also	ADV
ajbspi-70150	48	4	play	play	VERB
ajbspi-70150	48	5	a	a	DET
ajbspi-70150	48	6	role	role	NOUN
ajbspi-70150	48	7	,	,	PUNCT
ajbspi-70150	48	8	with	with	ADP
ajbspi-70150	48	9	postmenopausal	postmenopausal	ADJ
ajbspi-70150	48	10	women	woman	NOUN
ajbspi-70150	48	11	at	at	ADP
ajbspi-70150	48	12	increased	increase	VERB
ajbspi-70150	48	13	risk	risk	NOUN
ajbspi-70150	48	14	of	of	ADP
ajbspi-70150	48	15	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	48	16	due	due	ADP
ajbspi-70150	48	17	to	to	ADP
ajbspi-70150	48	18	the	the	DET
ajbspi-70150	48	19	loss	loss	NOUN
ajbspi-70150	48	20	of	of	ADP
ajbspi-70150	48	21	the	the	DET
ajbspi-70150	48	22	protective	protective	ADJ
ajbspi-70150	48	23	cardiovascular	cardiovascular	ADJ
ajbspi-70150	48	24	effects	effect	NOUN
ajbspi-70150	48	25	of	of	ADP
ajbspi-70150	48	26	estrogen	estrogen	NOUN
ajbspi-70150	48	27	.	.	PUNCT
ajbspi-70150	49	1	medications	medication	NOUN
ajbspi-70150	49	2	and	and	CCONJ
ajbspi-70150	49	3	treatment	treatment	NOUN
ajbspi-70150	49	4	-	-	PUNCT
ajbspi-70150	49	5	related	relate	VERB
ajbspi-70150	49	6	factors	factor	NOUN
ajbspi-70150	49	7	.	.	PUNCT
ajbspi-70150	50	1	the	the	DET
ajbspi-70150	50	2	treatment	treatment	NOUN
ajbspi-70150	50	3	of	of	ADP
ajbspi-70150	50	4	systemic	systemic	ADJ
ajbspi-70150	50	5	scleroderma	scleroderma	NOUN
ajbspi-70150	50	6	itself	itself	PRON
ajbspi-70150	50	7	may	may	AUX
ajbspi-70150	50	8	contribute	contribute	VERB
ajbspi-70150	50	9	to	to	ADP
ajbspi-70150	50	10	cardiovascular	cardiovascular	ADJ
ajbspi-70150	50	11	risk	risk	NOUN
ajbspi-70150	50	12	.	.	PUNCT
ajbspi-70150	51	1	corticosteroids	corticosteroid	NOUN
ajbspi-70150	51	2	,	,	PUNCT
ajbspi-70150	51	3	commonly	commonly	ADV
ajbspi-70150	51	4	prescribed	prescribe	VERB
ajbspi-70150	51	5	for	for	ADP
ajbspi-70150	51	6	ssc	ssc	NOUN
ajbspi-70150	51	7	,	,	PUNCT
ajbspi-70150	51	8	can	can	AUX
ajbspi-70150	51	9	lead	lead	VERB
ajbspi-70150	51	10	to	to	ADP
ajbspi-70150	51	11	increased	increase	VERB
ajbspi-70150	51	12	blood	blood	NOUN
ajbspi-70150	51	13	pressure	pressure	NOUN
ajbspi-70150	51	14	,	,	PUNCT
ajbspi-70150	51	15	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	51	16	,	,	PUNCT
ajbspi-70150	51	17	and	and	CCONJ
ajbspi-70150	51	18	insulin	insulin	NOUN
ajbspi-70150	51	19	resistance	resistance	NOUN
ajbspi-70150	51	20	,	,	PUNCT
ajbspi-70150	51	21	all	all	PRON
ajbspi-70150	51	22	of	of	ADP
ajbspi-70150	51	23	which	which	PRON
ajbspi-70150	51	24	are	be	AUX
ajbspi-70150	51	25	risk	risk	NOUN
ajbspi-70150	51	26	factors	factor	NOUN
ajbspi-70150	51	27	for	for	ADP
ajbspi-70150	51	28	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	51	29	[	[	X
ajbspi-70150	51	30	6,7	6,7	NUM
ajbspi-70150	51	31	]	]	PUNCT
ajbspi-70150	51	32	.	.	PUNCT
ajbspi-70150	52	1	additionally	additionally	ADV
ajbspi-70150	52	2	,	,	PUNCT
ajbspi-70150	52	3	some	some	DET
ajbspi-70150	52	4	immunosuppressive	immunosuppressive	ADJ
ajbspi-70150	52	5	therapies	therapy	NOUN
ajbspi-70150	52	6	used	use	VERB
ajbspi-70150	52	7	in	in	ADP
ajbspi-70150	52	8	ssc	ssc	PROPN
ajbspi-70150	52	9	,	,	PUNCT
ajbspi-70150	52	10	such	such	ADJ
ajbspi-70150	52	11	as	as	ADP
ajbspi-70150	52	12	cyclophosphamide	cyclophosphamide	NOUN
ajbspi-70150	52	13	,	,	PUNCT
ajbspi-70150	52	14	may	may	AUX
ajbspi-70150	52	15	indirectly	indirectly	ADV
ajbspi-70150	52	16	increase	increase	VERB
ajbspi-70150	52	17	cardiovascular	cardiovascular	ADJ
ajbspi-70150	52	18	risk	risk	NOUN
ajbspi-70150	52	19	by	by	ADP
ajbspi-70150	52	20	promoting	promote	VERB
ajbspi-70150	52	21	endothelial	endothelial	ADJ
ajbspi-70150	52	22	dysfunction	dysfunction	NOUN
ajbspi-70150	52	23	and	and	CCONJ
ajbspi-70150	52	24	contributing	contribute	VERB
ajbspi-70150	52	25	to	to	PART
ajbspi-70150	52	26	vascular	vascular	VERB
ajbspi-70150	52	27	remodeling	remodeling	NOUN
ajbspi-70150	52	28	.	.	PUNCT
ajbspi-70150	53	1	obesity	obesity	NOUN
ajbspi-70150	53	2	and	and	CCONJ
ajbspi-70150	53	3	sedentary	sedentary	ADJ
ajbspi-70150	53	4	lifestyle	lifestyle	NOUN
ajbspi-70150	53	5	.	.	PUNCT
ajbspi-70150	54	1	patients	patient	NOUN
ajbspi-70150	54	2	with	with	ADP
ajbspi-70150	54	3	systemic	systemic	ADJ
ajbspi-70150	54	4	scleroderma	scleroderma	NOUN
ajbspi-70150	54	5	often	often	ADV
ajbspi-70150	54	6	experience	experience	VERB
ajbspi-70150	54	7	reduced	reduce	VERB
ajbspi-70150	54	8	american	american	ADJ
ajbspi-70150	54	9	journal	journal	PROPN
ajbspi-70150	54	10	of	of	ADP
ajbspi-70150	54	11	applied	apply	VERB
ajbspi-70150	54	12	science	science	NOUN
ajbspi-70150	54	13	and	and	CCONJ
ajbspi-70150	54	14	technology	technology	NOUN
ajbspi-70150	54	15	19	19	NUM
ajbspi-70150	54	16	https://theusajournals.com/index.php/ajast	https://theusajournals.com/index.php/ajast	NOUN
ajbspi-70150	54	17	american	american	PROPN
ajbspi-70150	54	18	journal	journal	PROPN
ajbspi-70150	54	19	of	of	ADP
ajbspi-70150	54	20	applied	apply	VERB
ajbspi-70150	54	21	science	science	NOUN
ajbspi-70150	54	22	and	and	CCONJ
ajbspi-70150	54	23	technology	technology	NOUN
ajbspi-70150	54	24	(	(	PUNCT
ajbspi-70150	54	25	issn	issn	PROPN
ajbspi-70150	54	26	:	:	PUNCT
ajbspi-70150	54	27	2771	2771	NUM
ajbspi-70150	54	28	-	-	SYM
ajbspi-70150	54	29	2745	2745	NUM
ajbspi-70150	54	30	)	)	PUNCT
ajbspi-70150	54	31	physical	physical	ADJ
ajbspi-70150	54	32	activity	activity	NOUN
ajbspi-70150	54	33	due	due	ADP
ajbspi-70150	54	34	to	to	ADP
ajbspi-70150	54	35	musculoskeletal	musculoskeletal	ADJ
ajbspi-70150	54	36	involvement	involvement	NOUN
ajbspi-70150	54	37	,	,	PUNCT
ajbspi-70150	54	38	joint	joint	ADJ
ajbspi-70150	54	39	stiffness	stiffness	NOUN
ajbspi-70150	54	40	,	,	PUNCT
ajbspi-70150	54	41	and	and	CCONJ
ajbspi-70150	54	42	skin	skin	NOUN
ajbspi-70150	54	43	tightness	tightness	NOUN
ajbspi-70150	54	44	,	,	PUNCT
ajbspi-70150	54	45	which	which	PRON
ajbspi-70150	54	46	can	can	AUX
ajbspi-70150	54	47	contribute	contribute	VERB
ajbspi-70150	54	48	to	to	ADP
ajbspi-70150	54	49	obesity	obesity	NOUN
ajbspi-70150	54	50	and	and	CCONJ
ajbspi-70150	54	51	metabolic	metabolic	NOUN
ajbspi-70150	54	52	syndrome	syndrome	NOUN
ajbspi-70150	54	53	.	.	PUNCT
ajbspi-70150	55	1	obesity	obesity	NOUN
ajbspi-70150	55	2	,	,	PUNCT
ajbspi-70150	55	3	in	in	ADP
ajbspi-70150	55	4	turn	turn	NOUN
ajbspi-70150	55	5	,	,	PUNCT
ajbspi-70150	55	6	is	be	AUX
ajbspi-70150	55	7	a	a	DET
ajbspi-70150	55	8	well	well	ADV
ajbspi-70150	55	9	-	-	PUNCT
ajbspi-70150	55	10	known	know	VERB
ajbspi-70150	55	11	risk	risk	NOUN
ajbspi-70150	55	12	factor	factor	NOUN
ajbspi-70150	55	13	for	for	ADP
ajbspi-70150	55	14	the	the	DET
ajbspi-70150	55	15	development	development	NOUN
ajbspi-70150	55	16	of	of	ADP
ajbspi-70150	55	17	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	55	18	.	.	PUNCT
ajbspi-70150	56	1	sedentary	sedentary	ADJ
ajbspi-70150	56	2	behavior	behavior	NOUN
ajbspi-70150	56	3	,	,	PUNCT
ajbspi-70150	56	4	combined	combine	VERB
ajbspi-70150	56	5	with	with	ADP
ajbspi-70150	56	6	obesity	obesity	NOUN
ajbspi-70150	56	7	,	,	PUNCT
ajbspi-70150	56	8	exacerbates	exacerbate	VERB
ajbspi-70150	56	9	the	the	DET
ajbspi-70150	56	10	risk	risk	NOUN
ajbspi-70150	56	11	of	of	ADP
ajbspi-70150	56	12	developing	develop	VERB
ajbspi-70150	56	13	cardiovascular	cardiovascular	ADJ
ajbspi-70150	56	14	diseases	disease	NOUN
ajbspi-70150	56	15	in	in	ADP
ajbspi-70150	56	16	these	these	DET
ajbspi-70150	56	17	patients	patient	NOUN
ajbspi-70150	56	18	.	.	PUNCT
ajbspi-70150	57	1	management	management	NOUN
ajbspi-70150	57	2	and	and	CCONJ
ajbspi-70150	57	3	prevention	prevention	NOUN
ajbspi-70150	57	4	.	.	PUNCT
ajbspi-70150	58	1	given	give	VERB
ajbspi-70150	58	2	the	the	DET
ajbspi-70150	58	3	elevated	elevated	ADJ
ajbspi-70150	58	4	cardiovascular	cardiovascular	ADJ
ajbspi-70150	58	5	risk	risk	NOUN
ajbspi-70150	58	6	in	in	ADP
ajbspi-70150	58	7	patients	patient	NOUN
ajbspi-70150	58	8	with	with	ADP
ajbspi-70150	58	9	systemic	systemic	ADJ
ajbspi-70150	58	10	scleroderma	scleroderma	NOUN
ajbspi-70150	58	11	,	,	PUNCT
ajbspi-70150	58	12	early	early	ADV
ajbspi-70150	58	13	screening	screen	VERB
ajbspi-70150	58	14	for	for	ADP
ajbspi-70150	58	15	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	58	16	is	be	AUX
ajbspi-70150	58	17	essential	essential	ADJ
ajbspi-70150	58	18	.	.	PUNCT
ajbspi-70150	59	1	regular	regular	ADJ
ajbspi-70150	59	2	monitoring	monitoring	NOUN
ajbspi-70150	59	3	of	of	ADP
ajbspi-70150	59	4	blood	blood	NOUN
ajbspi-70150	59	5	pressure	pressure	NOUN
ajbspi-70150	59	6	,	,	PUNCT
ajbspi-70150	59	7	lipid	lipid	NOUN
ajbspi-70150	59	8	profiles	profile	NOUN
ajbspi-70150	59	9	,	,	PUNCT
ajbspi-70150	59	10	and	and	CCONJ
ajbspi-70150	59	11	markers	marker	NOUN
ajbspi-70150	59	12	of	of	ADP
ajbspi-70150	59	13	inflammation	inflammation	NOUN
ajbspi-70150	59	14	is	be	AUX
ajbspi-70150	59	15	recommended	recommend	VERB
ajbspi-70150	59	16	to	to	PART
ajbspi-70150	59	17	identify	identify	VERB
ajbspi-70150	59	18	those	those	PRON
ajbspi-70150	59	19	at	at	ADP
ajbspi-70150	59	20	greatest	great	ADJ
ajbspi-70150	59	21	risk	risk	NOUN
ajbspi-70150	59	22	for	for	ADP
ajbspi-70150	59	23	atherosclerotic	atherosclerotic	ADJ
ajbspi-70150	59	24	cardiovascular	cardiovascular	ADJ
ajbspi-70150	59	25	events	event	NOUN
ajbspi-70150	59	26	.	.	PUNCT
ajbspi-70150	60	1	non	non	ADJ
ajbspi-70150	60	2	-	-	ADJ
ajbspi-70150	60	3	invasive	invasive	ADJ
ajbspi-70150	60	4	imaging	imaging	NOUN
ajbspi-70150	60	5	techniques	technique	NOUN
ajbspi-70150	60	6	,	,	PUNCT
ajbspi-70150	60	7	such	such	ADJ
ajbspi-70150	60	8	as	as	ADP
ajbspi-70150	60	9	carotid	carotid	ADJ
ajbspi-70150	60	10	ultrasonography	ultrasonography	NOUN
ajbspi-70150	60	11	,	,	PUNCT
ajbspi-70150	60	12	can	can	AUX
ajbspi-70150	60	13	help	help	VERB
ajbspi-70150	60	14	assess	assess	VERB
ajbspi-70150	60	15	the	the	DET
ajbspi-70150	60	16	presence	presence	NOUN
ajbspi-70150	60	17	and	and	CCONJ
ajbspi-70150	60	18	severity	severity	NOUN
ajbspi-70150	60	19	of	of	ADP
ajbspi-70150	60	20	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	60	21	in	in	ADP
ajbspi-70150	60	22	ssc	ssc	NOUN
ajbspi-70150	60	23	patients	patient	NOUN
ajbspi-70150	61	1	[	[	X
ajbspi-70150	61	2	9	9	NUM
ajbspi-70150	61	3	]	]	PUNCT
ajbspi-70150	61	4	.	.	PUNCT
ajbspi-70150	62	1	management	management	NOUN
ajbspi-70150	62	2	strategies	strategy	NOUN
ajbspi-70150	62	3	should	should	AUX
ajbspi-70150	62	4	include	include	VERB
ajbspi-70150	62	5	aggressive	aggressive	ADJ
ajbspi-70150	62	6	control	control	NOUN
ajbspi-70150	62	7	of	of	ADP
ajbspi-70150	62	8	traditional	traditional	ADJ
ajbspi-70150	62	9	risk	risk	NOUN
ajbspi-70150	62	10	factors	factor	NOUN
ajbspi-70150	62	11	,	,	PUNCT
ajbspi-70150	62	12	such	such	ADJ
ajbspi-70150	62	13	as	as	ADP
ajbspi-70150	62	14	hypertension	hypertension	NOUN
ajbspi-70150	62	15	and	and	CCONJ
ajbspi-70150	62	16	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	62	17	,	,	PUNCT
ajbspi-70150	62	18	as	as	ADV
ajbspi-70150	62	19	well	well	ADV
ajbspi-70150	62	20	as	as	ADP
ajbspi-70150	62	21	the	the	DET
ajbspi-70150	62	22	treatment	treatment	NOUN
ajbspi-70150	62	23	of	of	ADP
ajbspi-70150	62	24	the	the	DET
ajbspi-70150	62	25	underlying	underlie	VERB
ajbspi-70150	62	26	autoimmune	autoimmune	ADJ
ajbspi-70150	62	27	and	and	CCONJ
ajbspi-70150	62	28	inflammatory	inflammatory	ADJ
ajbspi-70150	62	29	components	component	NOUN
ajbspi-70150	62	30	of	of	ADP
ajbspi-70150	62	31	systemic	systemic	ADJ
ajbspi-70150	62	32	scleroderma	scleroderma	NOUN
ajbspi-70150	62	33	.	.	PUNCT
ajbspi-70150	63	1	statins	statin	NOUN
ajbspi-70150	63	2	,	,	PUNCT
ajbspi-70150	63	3	angiotensin	angiotensin	NOUN
ajbspi-70150	63	4	-	-	PUNCT
ajbspi-70150	63	5	converting	convert	VERB
ajbspi-70150	63	6	enzyme	enzyme	NOUN
ajbspi-70150	63	7	inhibitors	inhibitor	NOUN
ajbspi-70150	63	8	(	(	PUNCT
ajbspi-70150	63	9	ace	ace	VERB
ajbspi-70150	63	10	inhibitors	inhibitor	NOUN
ajbspi-70150	63	11	)	)	PUNCT
ajbspi-70150	63	12	,	,	PUNCT
ajbspi-70150	63	13	and	and	CCONJ
ajbspi-70150	63	14	other	other	ADJ
ajbspi-70150	63	15	cardiovascular	cardiovascular	ADJ
ajbspi-70150	63	16	agents	agent	NOUN
ajbspi-70150	63	17	should	should	AUX
ajbspi-70150	63	18	be	be	AUX
ajbspi-70150	63	19	considered	consider	VERB
ajbspi-70150	63	20	based	base	VERB
ajbspi-70150	63	21	on	on	ADP
ajbspi-70150	63	22	individual	individual	ADJ
ajbspi-70150	63	23	risk	risk	NOUN
ajbspi-70150	63	24	profiles	profile	NOUN
ajbspi-70150	63	25	[	[	X
ajbspi-70150	63	26	10	10	NUM
ajbspi-70150	63	27	]	]	PUNCT
ajbspi-70150	63	28	.	.	PUNCT
ajbspi-70150	64	1	conclusion	conclusion	NOUN
ajbspi-70150	64	2	patients	patient	NOUN
ajbspi-70150	64	3	with	with	ADP
ajbspi-70150	64	4	systemic	systemic	ADJ
ajbspi-70150	64	5	scleroderma	scleroderma	NOUN
ajbspi-70150	64	6	are	be	AUX
ajbspi-70150	64	7	at	at	ADP
ajbspi-70150	64	8	an	an	DET
ajbspi-70150	64	9	increased	increase	VERB
ajbspi-70150	64	10	risk	risk	NOUN
ajbspi-70150	64	11	of	of	ADP
ajbspi-70150	64	12	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	64	13	due	due	ADP
ajbspi-70150	64	14	to	to	ADP
ajbspi-70150	64	15	a	a	DET
ajbspi-70150	64	16	combination	combination	NOUN
ajbspi-70150	64	17	of	of	ADP
ajbspi-70150	64	18	endothelial	endothelial	ADJ
ajbspi-70150	64	19	dysfunction	dysfunction	NOUN
ajbspi-70150	64	20	,	,	PUNCT
ajbspi-70150	64	21	chronic	chronic	ADJ
ajbspi-70150	64	22	inflammation	inflammation	NOUN
ajbspi-70150	64	23	,	,	PUNCT
ajbspi-70150	64	24	dyslipidemia	dyslipidemia	NOUN
ajbspi-70150	64	25	,	,	PUNCT
ajbspi-70150	64	26	and	and	CCONJ
ajbspi-70150	64	27	other	other	ADJ
ajbspi-70150	64	28	disease	disease	NOUN
ajbspi-70150	64	29	-	-	PUNCT
ajbspi-70150	64	30	specific	specific	ADJ
ajbspi-70150	64	31	factors	factor	NOUN
ajbspi-70150	64	32	.	.	PUNCT
ajbspi-70150	65	1	the	the	DET
ajbspi-70150	65	2	early	early	ADJ
ajbspi-70150	65	3	identification	identification	NOUN
ajbspi-70150	65	4	of	of	ADP
ajbspi-70150	65	5	these	these	DET
ajbspi-70150	65	6	risk	risk	NOUN
ajbspi-70150	65	7	factors	factor	NOUN
ajbspi-70150	65	8	and	and	CCONJ
ajbspi-70150	65	9	the	the	DET
ajbspi-70150	65	10	implementation	implementation	NOUN
ajbspi-70150	65	11	of	of	ADP
ajbspi-70150	65	12	targeted	target	VERB
ajbspi-70150	65	13	interventions	intervention	NOUN
ajbspi-70150	65	14	are	be	AUX
ajbspi-70150	65	15	crucial	crucial	ADJ
ajbspi-70150	65	16	to	to	PART
ajbspi-70150	65	17	reduce	reduce	VERB
ajbspi-70150	65	18	the	the	DET
ajbspi-70150	65	19	cardiovascular	cardiovascular	ADJ
ajbspi-70150	65	20	morbidity	morbidity	NOUN
ajbspi-70150	65	21	and	and	CCONJ
ajbspi-70150	65	22	mortality	mortality	NOUN
ajbspi-70150	65	23	in	in	ADP
ajbspi-70150	65	24	this	this	DET
ajbspi-70150	65	25	patient	patient	ADJ
ajbspi-70150	65	26	population	population	NOUN
ajbspi-70150	65	27	.	.	PUNCT
ajbspi-70150	66	1	clinicians	clinician	NOUN
ajbspi-70150	66	2	must	must	AUX
ajbspi-70150	66	3	be	be	AUX
ajbspi-70150	66	4	vigilant	vigilant	ADJ
ajbspi-70150	66	5	in	in	ADP
ajbspi-70150	66	6	monitoring	monitor	VERB
ajbspi-70150	66	7	for	for	ADP
ajbspi-70150	66	8	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	66	9	in	in	ADP
ajbspi-70150	66	10	systemic	systemic	ADJ
ajbspi-70150	66	11	scleroderma	scleroderma	NOUN
ajbspi-70150	66	12	and	and	CCONJ
ajbspi-70150	66	13	take	take	VERB
ajbspi-70150	66	14	an	an	DET
ajbspi-70150	66	15	integrated	integrated	ADJ
ajbspi-70150	66	16	approach	approach	NOUN
ajbspi-70150	66	17	to	to	ADP
ajbspi-70150	66	18	the	the	DET
ajbspi-70150	66	19	management	management	NOUN
ajbspi-70150	66	20	of	of	ADP
ajbspi-70150	66	21	cardiovascular	cardiovascular	ADJ
ajbspi-70150	66	22	risk	risk	NOUN
ajbspi-70150	66	23	.	.	PUNCT
ajbspi-70150	67	1	references	reference	NOUN
ajbspi-70150	67	2	bairkdar	bairkdar	PROPN
ajbspi-70150	67	3	m.	m.	NOUN
ajbspi-70150	67	4	,	,	PUNCT
ajbspi-70150	67	5	rossides	rosside	NOUN
ajbspi-70150	67	6	m.	m.	NOUN
ajbspi-70150	67	7	,	,	PUNCT
ajbspi-70150	67	8	westerlind	westerlind	PROPN
ajbspi-70150	67	9	h.	h.	PROPN
ajbspi-70150	67	10	,	,	PUNCT
ajbspi-70150	67	11	hesselstrand	hesselstrand	PROPN
ajbspi-70150	67	12	r.	r.	PROPN
ajbspi-70150	67	13	,	,	PUNCT
ajbspi-70150	67	14	arkema	arkema	VERB
ajbspi-70150	67	15	e.v	e.v	PROPN
ajbspi-70150	67	16	.	.	PROPN
ajbspi-70150	67	17	,	,	PUNCT
ajbspi-70150	67	18	holmqvist	holmqvist	NOUN
ajbspi-70150	67	19	m.	m.	NOUN
ajbspi-70150	67	20	incidence	incidence	NOUN
ajbspi-70150	67	21	and	and	CCONJ
ajbspi-70150	67	22	prevalence	prevalence	NOUN
ajbspi-70150	67	23	of	of	ADP
ajbspi-70150	67	24	systemic	systemic	ADJ
ajbspi-70150	67	25	sclerosis	sclerosis	NOUN
ajbspi-70150	67	26	globally	globally	ADV
ajbspi-70150	67	27	:	:	PUNCT
ajbspi-70150	67	28	a	a	DET
ajbspi-70150	67	29	comprehensive	comprehensive	ADJ
ajbspi-70150	67	30	systematic	systematic	ADJ
ajbspi-70150	67	31	review	review	NOUN
ajbspi-70150	67	32	and	and	CCONJ
ajbspi-70150	67	33	metaanalysis	metaanalysis	NOUN
ajbspi-70150	67	34	//	//	X
ajbspi-70150	67	35	rheumatology	rheumatology	NOUN
ajbspi-70150	67	36	(	(	PUNCT
ajbspi-70150	67	37	oxford	oxford	PROPN
ajbspi-70150	67	38	,	,	PUNCT
ajbspi-70150	67	39	england	england	PROPN
ajbspi-70150	67	40	)	)	PUNCT
ajbspi-70150	67	41	.	.	PUNCT
ajbspi-70150	68	1	2021	2021	NUM
ajbspi-70150	68	2	.	.	PUNCT
ajbspi-70150	69	1	№	№	NOUN
ajbspi-70150	69	2	60	60	NUM
ajbspi-70150	69	3	.	.	PUNCT
ajbspi-70150	70	1	–	–	PUNCT
ajbspi-70150	70	2	p.3121–3133	p.3121–3133	NOUN
ajbspi-70150	70	3	.	.	PUNCT
ajbspi-70150	70	4	brown	brown	ADJ
ajbspi-70150	70	5	m.	m.	NOUN
ajbspi-70150	70	6	,	,	PUNCT
ajbspi-70150	70	7	o’reilly	o’reilly	ADV
ajbspi-70150	70	8	s.	s.	VERB
ajbspi-70150	70	9	the	the	DET
ajbspi-70150	70	10	immunopathogenesis	immunopathogenesis	NOUN
ajbspi-70150	70	11	of	of	ADP
ajbspi-70150	70	12	fibrosis	fibrosis	NOUN
ajbspi-70150	70	13	in	in	ADP
ajbspi-70150	70	14	systemic	systemic	ADJ
ajbspi-70150	70	15	sclerosis	sclerosis	NOUN
ajbspi-70150	70	16	//	//	PUNCT
ajbspi-70150	70	17	clinical	clinical	ADJ
ajbspi-70150	70	18	and	and	CCONJ
ajbspi-70150	70	19	experimental	experimental	ADJ
ajbspi-70150	70	20	immunology	immunology	NOUN
ajbspi-70150	70	21	.	.	PUNCT
ajbspi-70150	71	1	2019	2019	NUM
ajbspi-70150	71	2	.	.	PUNCT
ajbspi-70150	72	1	№	№	ADJ
ajbspi-70150	72	2	195.p.310	195.p.310	NUM
ajbspi-70150	72	3	–	–	PUNCT
ajbspi-70150	72	4	321	321	NUM
ajbspi-70150	72	5	.	.	PUNCT
ajbspi-70150	72	6	cassius	cassius	PROPN
ajbspi-70150	72	7	c.	c.	PROPN
ajbspi-70150	72	8	,	,	PUNCT
ajbspi-70150	72	9	seta	seta	PROPN
ajbspi-70150	72	10	v.	v.	PROPN
ajbspi-70150	72	11	,	,	PUNCT
ajbspi-70150	72	12	monfort	monfort	NOUN
ajbspi-70150	72	13	j.b	j.b	PROPN
ajbspi-70150	72	14	.	.	PROPN
ajbspi-70150	72	15	,	,	PUNCT
ajbspi-70150	72	16	baudot	baudot	PROPN
ajbspi-70150	72	17	n.a	n.a	PROPN
ajbspi-70150	72	18	.	.	PROPN
ajbspi-70150	72	19	,	,	PUNCT
ajbspi-70150	72	20	rivière	rivière	PROPN
ajbspi-70150	72	21	s.	s.	PROPN
ajbspi-70150	72	22	,	,	PUNCT
ajbspi-70150	72	23	mekinian	mekinian	PROPN
ajbspi-70150	72	24	a.	a.	PROPN
ajbspi-70150	72	25	,	,	PUNCT
ajbspi-70150	72	26	et	et	PROPN
ajbspi-70150	72	27	al	al	PROPN
ajbspi-70150	72	28	.	.	PUNCT
ajbspi-70150	73	1	systemic	systemic	ADJ
ajbspi-70150	73	2	sclerosis	sclerosis	NOUN
ajbspi-70150	73	3	is	be	AUX
ajbspi-70150	73	4	associated	associate	VERB
ajbspi-70150	73	5	with	with	ADP
ajbspi-70150	73	6	lower	low	ADJ
ajbspi-70150	73	7	limb	limb	NOUN
ajbspi-70150	73	8	vascular	vascular	ADJ
ajbspi-70150	73	9	stiffness	stiffness	NOUN
ajbspi-70150	73	10	and	and	CCONJ
ajbspi-70150	73	11	microvascular	microvascular	ADJ
ajbspi-70150	73	12	impairment	impairment	NOUN
ajbspi-70150	73	13	:	:	PUNCT
ajbspi-70150	73	14	results	result	NOUN
ajbspi-70150	73	15	from	from	ADP
ajbspi-70150	73	16	a	a	DET
ajbspi-70150	73	17	prospective	prospective	ADJ
ajbspi-70150	73	18	study	study	NOUN
ajbspi-70150	73	19	.	.	PUNCT
ajbspi-70150	74	1	//	//	NUM
ajbspi-70150	74	2	clinical	clinical	ADJ
ajbspi-70150	74	3	rheumatology	rheumatology	NOUN
ajbspi-70150	74	4	.	.	PUNCT
ajbspi-70150	75	1	2021;	2021;	NUM
ajbspi-70150	75	2	№	№	NUM
ajbspi-70150	75	3	40	40	NUM
ajbspi-70150	75	4	.	.	PUNCT
ajbspi-70150	76	1	–	–	PUNCT
ajbspi-70150	76	2	p.3679–3686	p.3679–3686	ADJ
ajbspi-70150	76	3	.	.	PUNCT
ajbspi-70150	76	4	ganiyeva	ganiyeva	PROPN
ajbspi-70150	76	5	n.a	n.a	PROPN
ajbspi-70150	76	6	.	.	PROPN
ajbspi-70150	76	7	,	,	PUNCT
ajbspi-70150	76	8	rizamukhamedova	rizamukhamedova	VERB
ajbspi-70150	77	1	m.z	m.z	NOUN
ajbspi-70150	77	2	.	.	PROPN
ajbspi-70150	77	3	,	,	PUNCT
ajbspi-70150	77	4	nabiyeva	nabiyeva	PROPN
ajbspi-70150	77	5	d.a	d.a	PROPN
ajbspi-70150	77	6	.	.	PROPN
ajbspi-70150	77	7	,	,	PUNCT
ajbspi-70150	77	8	aripova	aripova	PROPN
ajbspi-70150	77	9	n.a	n.a	PROPN
ajbspi-70150	77	10	.	.	PROPN
ajbspi-70150	77	11	clinic	clinic	PROPN
ajbspi-70150	77	12	diagnostic	diagnostic	ADJ
ajbspi-70150	77	13	aspects	aspect	NOUN
ajbspi-70150	77	14	of	of	ADP
ajbspi-70150	77	15	modern	modern	ADJ
ajbspi-70150	77	16	biomarkers	biomarker	NOUN
ajbspi-70150	77	17	of	of	ADP
ajbspi-70150	77	18	early	early	ADJ
ajbspi-70150	77	19	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	77	20	and	and	CCONJ
ajbspi-70150	77	21	fibrotic	fibrotic	ADJ
ajbspi-70150	77	22	activity	activity	NOUN
ajbspi-70150	77	23	of	of	ADP
ajbspi-70150	77	24	systemic	systemic	ADJ
ajbspi-70150	77	25	scleroderma	scleroderma	NOUN
ajbspi-70150	77	26	//	//	NUM
ajbspi-70150	77	27	asian	asian	PROPN
ajbspi-70150	77	28	journal	journal	PROPN
ajbspi-70150	77	29	of	of	ADP
ajbspi-70150	77	30	medical	medical	ADJ
ajbspi-70150	77	31	principles	principle	NOUN
ajbspi-70150	77	32	and	and	CCONJ
ajbspi-70150	77	33	clinical	clinical	ADJ
ajbspi-70150	77	34	practice	practice	NOUN
ajbspi-70150	77	35	.	.	PUNCT
ajbspi-70150	78	1	2021.	2021.	NUM
ajbspi-70150	78	2	№	№	ADJ
ajbspi-70150	78	3	4(3	4(3	NUM
ajbspi-70150	78	4	)	)	PUNCT
ajbspi-70150	78	5	.	.	PUNCT
ajbspi-70150	79	1	p.1	p.1	NOUN
ajbspi-70150	79	2	-	-	SYM
ajbspi-70150	79	3	13	13	NUM
ajbspi-70150	79	4	.	.	PUNCT
ajbspi-70150	80	1	gigante	gigante	PROPN
ajbspi-70150	80	2	a.	a.	PROPN
ajbspi-70150	80	3	,	,	PUNCT
ajbspi-70150	80	4	navarini	navarini	PROPN
ajbspi-70150	80	5	l.	l.	PROPN
ajbspi-70150	80	6	,	,	PUNCT
ajbspi-70150	80	7	margiotta	margiotta	PROPN
ajbspi-70150	80	8	d.	d.	PROPN
ajbspi-70150	80	9	,	,	PUNCT
ajbspi-70150	80	10	amoroso	amoroso	PROPN
ajbspi-70150	80	11	a.	a.	PROPN
ajbspi-70150	80	12	,	,	PUNCT
ajbspi-70150	80	13	barbano	barbano	PROPN
ajbspi-70150	80	14	b.	b.	PROPN
ajbspi-70150	80	15	,	,	PUNCT
ajbspi-70150	80	16	cianci	cianci	PROPN
ajbspi-70150	80	17	r.	r.	PROPN
ajbspi-70150	80	18	,	,	PUNCT
ajbspi-70150	80	19	et	et	PROPN
ajbspi-70150	80	20	al	al	PROPN
ajbspi-70150	80	21	.	.	PROPN
ajbspi-70150	80	22	angiogenic	angiogenic	PROPN
ajbspi-70150	80	23	and	and	CCONJ
ajbspi-70150	80	24	angiostatic	angiostatic	ADJ
ajbspi-70150	80	25	factors	factor	NOUN
ajbspi-70150	80	26	in	in	ADP
ajbspi-70150	80	27	renal	renal	ADJ
ajbspi-70150	80	28	scleroderma	scleroderma	NOUN
ajbspi-70150	80	29	-	-	PUNCT
ajbspi-70150	80	30	associated	associate	VERB
ajbspi-70150	80	31	vasculopathy	vasculopathy	NOUN
ajbspi-70150	80	32	//	//	SYM
ajbspi-70150	80	33	microvascular	microvascular	NOUN
ajbspi-70150	80	34	research	research	NOUN
ajbspi-70150	80	35	.	.	PUNCT
ajbspi-70150	81	1	–	–	PUNCT
ajbspi-70150	81	2	2017	2017	NUM
ajbspi-70150	81	3	.	.	PUNCT
ajbspi-70150	82	1	№	№	NUM
ajbspi-70150	82	2	114	114	NUM
ajbspi-70150	82	3	.	.	PUNCT
ajbspi-70150	82	4	–	–	PUNCT
ajbspi-70150	82	5	p.	p.	NOUN
ajbspi-70150	82	6	41–45	41–45	NUM
ajbspi-70150	82	7	hesselvig	hesselvig	PROPN
ajbspi-70150	82	8	j.h	j.h	PROPN
ajbspi-70150	82	9	.	.	PROPN
ajbspi-70150	82	10	,	,	PUNCT
ajbspi-70150	82	11	kofoed	kofoed	PROPN
ajbspi-70150	82	12	k.	k.	PROPN
ajbspi-70150	82	13	,	,	PUNCT
ajbspi-70150	82	14	wu	wu	PROPN
ajbspi-70150	82	15	j.j	j.j	PROPN
ajbspi-70150	82	16	.	.	PROPN
ajbspi-70150	82	17	,	,	PUNCT
ajbspi-70150	82	18	dreyer	dreyer	PROPN
ajbspi-70150	82	19	l.	l.	PROPN
ajbspi-70150	82	20	,	,	PUNCT
ajbspi-70150	82	21	gislason	gislason	NOUN
ajbspi-70150	82	22	g.	g.	PROPN
ajbspi-70150	82	23	,	,	PUNCT
ajbspi-70150	82	24	ahlehoff	ahlehoff	ADP
ajbspi-70150	82	25	o.	o.	ADJ
ajbspi-70150	82	26	localized	localize	VERB
ajbspi-70150	82	27	scleroderma	scleroderma	NOUN
ajbspi-70150	82	28	,	,	PUNCT
ajbspi-70150	82	29	systemic	systemic	ADJ
ajbspi-70150	82	30	sclerosis	sclerosis	NOUN
ajbspi-70150	82	31	and	and	CCONJ
ajbspi-70150	82	32	cardiovascular	cardiovascular	ADJ
ajbspi-70150	82	33	risk	risk	NOUN
ajbspi-70150	82	34	:	:	PUNCT
ajbspi-70150	82	35	a	a	DET
ajbspi-70150	82	36	danish	danish	ADJ
ajbspi-70150	82	37	nationwide	nationwide	ADJ
ajbspi-70150	82	38	cohort	cohort	PROPN
ajbspi-70150	82	39	study	study	PROPN
ajbspi-70150	82	40	//	//	PROPN
ajbspi-70150	82	41	acta	acta	PROPN
ajbspi-70150	82	42	dermatovenereologica	dermatovenereologica	PROPN
ajbspi-70150	82	43	.	.	PUNCT
ajbspi-70150	83	1	–	–	PUNCT
ajbspi-70150	83	2	2018	2018	NUM
ajbspi-70150	83	3	.	.	PUNCT
ajbspi-70150	84	1	–	–	PUNCT
ajbspi-70150	84	2	№	№	NOUN
ajbspi-70150	84	3	98	98	NUM
ajbspi-70150	84	4	.	.	PUNCT
ajbspi-70150	84	5	–	–	PUNCT
ajbspi-70150	84	6	p.361–365	p.361–365	NOUN
ajbspi-70150	84	7	.	.	PUNCT
ajbspi-70150	85	1	kuley	kuley	PROPN
ajbspi-70150	85	2	r.	r.	PROPN
ajbspi-70150	85	3	,	,	PUNCT
ajbspi-70150	85	4	stultz	stultz	PROPN
ajbspi-70150	86	1	r.d	r.d	PRON
ajbspi-70150	86	2	.	.	PROPN
ajbspi-70150	86	3	,	,	PUNCT
ajbspi-70150	86	4	duvvuri	duvvuri	PROPN
ajbspi-70150	86	5	b.	b.	PROPN
ajbspi-70150	86	6	,	,	PUNCT
ajbspi-70150	86	7	wang	wang	PROPN
ajbspi-70150	86	8	t.	t.	PROPN
ajbspi-70150	86	9	,	,	PUNCT
ajbspi-70150	86	10	fritzler	fritzler	PROPN
ajbspi-70150	86	11	m.j	m.j	PROPN
ajbspi-70150	86	12	.	.	PROPN
ajbspi-70150	86	13	,	,	PUNCT
ajbspi-70150	86	14	hesselstrand	hesselstrand	PROPN
ajbspi-70150	86	15	r.	r.	PROPN
ajbspi-70150	86	16	,	,	PUNCT
ajbspi-70150	86	17	et	et	PROPN
ajbspi-70150	86	18	al	al	PROPN
ajbspi-70150	86	19	.	.	PROPN
ajbspi-70150	86	20	n	n	CCONJ
ajbspi-70150	86	21	-	-	PUNCT
ajbspi-70150	86	22	formyl	formyl	NOUN
ajbspi-70150	86	23	methionine	methionine	NOUN
ajbspi-70150	86	24	peptidemediated	peptidemediate	VERB
ajbspi-70150	86	25	neutrophil	neutrophil	ADJ
ajbspi-70150	86	26	activation	activation	NOUN
ajbspi-70150	86	27	in	in	ADP
ajbspi-70150	86	28	systemic	systemic	ADJ
ajbspi-70150	86	29	sclerosis	sclerosis	NOUN
ajbspi-70150	86	30	//	//	NUM
ajbspi-70150	86	31	frontiers	frontier	NOUN
ajbspi-70150	86	32	in	in	ADP
ajbspi-70150	86	33	immunology	immunology	NOUN
ajbspi-70150	86	34	.	.	PUNCT
ajbspi-70150	87	1	–	–	PUNCT
ajbspi-70150	87	2	2022	2022	NUM
ajbspi-70150	87	3	.	.	PUNCT
ajbspi-70150	88	1	№	№	ADP
ajbspi-70150	88	2	12	12	NUM
ajbspi-70150	88	3	.	.	PUNCT
ajbspi-70150	88	4	–	–	PUNCT
ajbspi-70150	88	5	p.785275	p.785275	PROPN
ajbspi-70150	88	6	.	.	PUNCT
ajbspi-70150	89	1	magda	magda	PROPN
ajbspi-70150	89	2	s.l	s.l	PROPN
ajbspi-70150	89	3	.	.	PROPN
ajbspi-70150	89	4	,	,	PUNCT
ajbspi-70150	89	5	mincu	mincu	PROPN
ajbspi-70150	89	6	r.i	r.i	PROPN
ajbspi-70150	89	7	.	.	PROPN
ajbspi-70150	89	8	,	,	PUNCT
ajbspi-70150	89	9	mihai	mihai	PROPN
ajbspi-70150	89	10	c.m	c.m	PROPN
ajbspi-70150	89	11	.	.	PROPN
ajbspi-70150	89	12	,	,	PUNCT
ajbspi-70150	89	13	cinteza	cinteza	NOUN
ajbspi-70150	89	14	m.	m.	NOUN
ajbspi-70150	89	15	,	,	PUNCT
ajbspi-70150	89	16	vinereanu	vinereanu	PROPN
ajbspi-70150	89	17	d.	d.	PROPN
ajbspi-70150	89	18	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	89	19	in	in	ADP
ajbspi-70150	89	20	systemic	systemic	ADJ
ajbspi-70150	89	21	sclerosis	sclerosis	NOUN
ajbspi-70150	89	22	:	:	PUNCT
ajbspi-70150	89	23	a	a	DET
ajbspi-70150	89	24	modern	modern	ADJ
ajbspi-70150	89	25	controversy	controversy	NOUN
ajbspi-70150	89	26	//	//	X
ajbspi-70150	89	27	maedica	maedica	PROPN
ajbspi-70150	89	28	(	(	PUNCT
ajbspi-70150	89	29	bucur	bucur	NOUN
ajbspi-70150	89	30	)	)	PUNCT
ajbspi-70150	89	31	.	.	PUNCT
ajbspi-70150	90	1	2015	2015	NUM
ajbspi-70150	90	2	sep	sep	NOUN
ajbspi-70150	90	3	.	.	PUNCT
ajbspi-70150	91	1	№	№	NOUN
ajbspi-70150	91	2	10(3	10(3	NUM
ajbspi-70150	91	3	)	)	PUNCT
ajbspi-70150	91	4	.	.	PUNCT
ajbspi-70150	92	1	–	–	PUNCT
ajbspi-70150	92	2	p.248	p.248	NOUN
ajbspi-70150	92	3	-	-	SYM
ajbspi-70150	92	4	256	256	NUM
ajbspi-70150	92	5	.	.	PUNCT
ajbspi-70150	93	1	nihtyanova	nihtyanova	PROPN
ajbspi-70150	93	2	s.i	s.i	PROPN
ajbspi-70150	93	3	.	.	PROPN
ajbspi-70150	93	4	,	,	PUNCT
ajbspi-70150	93	5	denton	denton	PROPN
ajbspi-70150	93	6	c.p	c.p	PROPN
ajbspi-70150	93	7	.	.	PROPN
ajbspi-70150	93	8	pathogenesis	pathogenesis	NOUN
ajbspi-70150	93	9	of	of	ADP
ajbspi-70150	93	10	systemic	systemic	ADJ
ajbspi-70150	93	11	sclerosis	sclerosis	NOUN
ajbspi-70150	93	12	associated	associate	VERB
ajbspi-70150	93	13	interstitial	interstitial	ADJ
ajbspi-70150	93	14	lung	lung	NOUN
ajbspi-70150	93	15	disease	disease	NOUN
ajbspi-70150	93	16	//	//	SYM
ajbspi-70150	93	17	journal	journal	PROPN
ajbspi-70150	93	18	of	of	ADP
ajbspi-70150	93	19	scleroderma	scleroderma	NOUN
ajbspi-70150	93	20	and	and	CCONJ
ajbspi-70150	93	21	related	related	ADJ
ajbspi-70150	93	22	disorders	disorder	NOUN
ajbspi-70150	93	23	.	.	PUNCT
ajbspi-70150	94	1	-2020	-2020	NOUN
ajbspi-70150	94	2	.	.	PUNCT
ajbspi-70150	94	3	-	-	PUNCT
ajbspi-70150	94	4	№	№	NOUN
ajbspi-70150	94	5	5	5	NUM
ajbspi-70150	94	6	.	.	PUNCT
ajbspi-70150	94	7	–	–	PUNCT
ajbspi-70150	94	8	p.6–16	p.6–16	NOUN
ajbspi-70150	94	9	.	.	PUNCT
ajbspi-70150	95	1	poznyak	poznyak	PROPN
ajbspi-70150	95	2	a.v	a.v	PROPN
ajbspi-70150	95	3	.	.	PROPN
ajbspi-70150	95	4	,	,	PUNCT
ajbspi-70150	95	5	bharadwaj	bharadwaj	PROPN
ajbspi-70150	95	6	d.	d.	PROPN
ajbspi-70150	95	7	,	,	PUNCT
ajbspi-70150	95	8	prasad	prasad	PROPN
ajbspi-70150	95	9	g.	g.	PROPN
ajbspi-70150	95	10	,	,	PUNCT
ajbspi-70150	96	1	grechko	grechko	PROPN
ajbspi-70150	96	2	a.v	a.v	PROPN
ajbspi-70150	96	3	.	.	PROPN
ajbspi-70150	96	4	,	,	PUNCT
ajbspi-70150	96	5	sazonova	sazonova	PROPN
ajbspi-70150	97	1	m.a	m.a	PROPN
ajbspi-70150	97	2	.	.	PROPN
ajbspi-70150	97	3	,	,	PUNCT
ajbspi-70150	97	4	orekhov	orekhov	PROPN
ajbspi-70150	97	5	a.n	a.n	PROPN
ajbspi-70150	97	6	.	.	PROPN
ajbspi-70150	97	7	renin	renin	ADJ
ajbspi-70150	97	8	-	-	PUNCT
ajbspi-70150	97	9	angiotensin	angiotensin	NOUN
ajbspi-70150	97	10	system	system	NOUN
ajbspi-70150	97	11	in	in	ADP
ajbspi-70150	97	12	pathogenesis	pathogenesis	NOUN
ajbspi-70150	97	13	of	of	ADP
ajbspi-70150	97	14	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	97	15	and	and	CCONJ
ajbspi-70150	97	16	treatment	treatment	NOUN
ajbspi-70150	97	17	of	of	ADP
ajbspi-70150	97	18	cvd	cvd	PROPN
ajbspi-70150	97	19	//	//	PROPN
ajbspi-70150	97	20	international	international	PROPN
ajbspi-70150	97	21	journal	journal	PROPN
ajbspi-70150	97	22	of	of	ADP
ajbspi-70150	97	23	molecular	molecular	ADJ
ajbspi-70150	97	24	sciences	science	NOUN
ajbspi-70150	97	25	.	.	PUNCT
ajbspi-70150	97	26	2021	2021	NUM
ajbspi-70150	97	27	.	.	PUNCT
ajbspi-70150	98	1	№	№	NOUN
ajbspi-70150	98	2	22	22	NUM
ajbspi-70150	98	3	.	.	PUNCT
ajbspi-70150	99	1	–	–	PUNCT
ajbspi-70150	99	2	p.6702	p.6702	NOUN
ajbspi-70150	99	3	.	.	PUNCT
ajbspi-70150	99	4	yoshizaki	yoshizaki	PROPN
ajbspi-70150	99	5	a.	a.	PROPN
ajbspi-70150	99	6	,	,	PUNCT
ajbspi-70150	99	7	fukasawa	fukasawa	PROPN
ajbspi-70150	99	8	t.	t.	PROPN
ajbspi-70150	99	9	,	,	PUNCT
ajbspi-70150	99	10	ebata	ebata	PROPN
ajbspi-70150	99	11	s.	s.	PROPN
ajbspi-70150	99	12	,	,	PUNCT
ajbspi-70150	99	13	yoshizaki	yoshizaki	NOUN
ajbspi-70150	99	14	-	-	PUNCT
ajbspi-70150	99	15	ogawa	ogawa	PROPN
ajbspi-70150	99	16	a.	a.	PROPN
ajbspi-70150	99	17	,	,	PUNCT
ajbspi-70150	99	18	sato	sato	PROPN
ajbspi-70150	99	19	s.	s.	PROPN
ajbspi-70150	99	20	involvement	involvement	PROPN
ajbspi-70150	99	21	of	of	ADP
ajbspi-70150	99	22	b	b	PROPN
ajbspi-70150	99	23	cells	cell	NOUN
ajbspi-70150	99	24	in	in	ADP
ajbspi-70150	99	25	the	the	DET
ajbspi-70150	99	26	development	development	NOUN
ajbspi-70150	99	27	of	of	ADP
ajbspi-70150	99	28	systemic	systemic	ADJ
ajbspi-70150	99	29	sclerosis	sclerosis	NOUN
ajbspi-70150	99	30	//	//	NUM
ajbspi-70150	99	31	frontiers	frontier	NOUN
ajbspi-70150	99	32	in	in	ADP
ajbspi-70150	99	33	immunology	immunology	NOUN
ajbspi-70150	99	34	.	.	PUNCT
ajbspi-70150	100	1	–	–	PUNCT
ajbspi-70150	100	2	2022	2022	NUM
ajbspi-70150	100	3	.	.	PUNCT
ajbspi-70150	101	1	№	№	ADP
ajbspi-70150	101	2	13	13	NUM
ajbspi-70150	101	3	.	.	PUNCT
ajbspi-70150	101	4	–	–	PUNCT
ajbspi-70150	101	5	p.938785	p.938785	X
ajbspi-70150	101	6	.	.	PUNCT
ajbspi-70150	102	1	zhu	zhu	PROPN
ajbspi-70150	102	2	y.	y.	PROPN
ajbspi-70150	102	3	,	,	PUNCT
ajbspi-70150	102	4	xian	xian	NOUN
ajbspi-70150	102	5	x.	x.	PROPN
ajbspi-70150	102	6	,	,	PUNCT
ajbspi-70150	102	7	wang	wang	PROPN
ajbspi-70150	102	8	z.	z.	PROPN
ajbspi-70150	102	9	,	,	PUNCT
ajbspi-70150	102	10	bi	bi	PROPN
ajbspi-70150	102	11	y.	y.	PROPN
ajbspi-70150	102	12	,	,	PUNCT
ajbspi-70150	102	13	chen	chen	PROPN
ajbspi-70150	102	14	q.	q.	PROPN
ajbspi-70150	102	15	,	,	PUNCT
ajbspi-70150	102	16	han	han	PROPN
ajbspi-70150	102	17	x.	x.	PROPN
ajbspi-70150	102	18	,	,	PUNCT
ajbspi-70150	102	19	et	et	PROPN
ajbspi-70150	102	20	al	al	PROPN
ajbspi-70150	102	21	.	.	PUNCT
ajbspi-70150	102	22	research	research	NOUN
ajbspi-70150	102	23	progress	progress	NOUN
ajbspi-70150	102	24	on	on	ADP
ajbspi-70150	102	25	the	the	DET
ajbspi-70150	102	26	relationship	relationship	NOUN
ajbspi-70150	102	27	between	between	ADP
ajbspi-70150	102	28	atherosclerosis	atherosclerosis	NOUN
ajbspi-70150	102	29	and	and	CCONJ
ajbspi-70150	102	30	inflammation	inflammation	NOUN
ajbspi-70150	102	31	//	//	SYM
ajbspi-70150	102	32	biomolecules	biomolecule	NOUN
ajbspi-70150	102	33	.	.	PUNCT
ajbspi-70150	102	34	–	–	PUNCT
ajbspi-70150	102	35	2018.	2018.	NUM
ajbspi-70150	102	36	№	№	ADJ
ajbspi-70150	102	37	8	8	NUM
ajbspi-70150	102	38	.	.	PUNCT
ajbspi-70150	102	39	–	–	PUNCT
ajbspi-70150	102	40	p.80	p.80	ADV
ajbspi-70150	102	41	.	.	PUNCT